Drug delivery device for delivering a predetermined fixed dose

By introducing helical and axial guiding transmission mechanisms into the drug delivery device, combined with torsion transmission springs and ratchet mechanisms, the complexity and safety issues of existing devices are resolved, enabling simple and safe fixed-dose delivery suitable for children or the elderly.

CN114828922BActive Publication Date: 2024-11-15NOVO NORDISK AS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080088040.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-12-18
Filing Date
2020-12-09
Publication Date
2024-11-15
Estimated Expiration
2040-12-09

AI Technical Summary

Technical Problem

Existing drug delivery devices present challenges in terms of complexity and safety when delivering fixed doses, especially for children or elderly users, where overdosing or underdosing is difficult to avoid, and the devices are also costly.

Method used

A drug delivery device has been designed, comprising a housing assembly, a transmission mechanism, and an activation mechanism. It utilizes a combination of a helical guide portion and an axial guide portion to achieve fixed-dose delivery through the axial and rotational motion of the transmission tube. A torsion transmission spring and a ratchet mechanism are employed to ensure safety and ease of use.

Benefits of technology

It enables simple, safe and robust fixed-dose drug delivery, reduces device complexity and cost, is suitable for use by children or the elderly, and ensures accurate dosage for each injection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114828922B_ABST
    Figure CN114828922B_ABST
Patent Text Reader

Abstract

A drug delivery device (100, 200) for delivering a fixed dose, wherein the drug delivery device comprises: a housing assembly; a drug reservoir having a piston; and a transmission mechanism. The transmission mechanism comprises a piston rod (109, 209) for advancing the piston to expel the drug; and a transmission tube (180, 280), wherein the transmission mechanism is adapted to deliver a predetermined fixed dose in response to activation. The drug delivery device also comprises an activation mechanism for activating the transmission mechanism in response to moving the transmission tube in an axial direction. The housing assembly comprises a guide structure for guiding the transmission tube during activation and delivery of a dose, wherein the guide structure comprises: an axial portion (156, 256) providing a sliding surface, the sliding surface of the axial portion being used to guide the transmission tube during activation and to provide a rotational stop defining an end point of the dose; and a helical portion (157, 257) providing a sliding surface, the sliding surface of the helical portion being adapted to guide the transmission tube (180, 280) during administration. The transmission tube (180, 280) includes a guide structure, which includes an axial portion (182, 282), which is suitable for slidably engaging the axial portion of the housing assembly for activation; and a spiral portion (189, 289), which is used to slidably engage the spiral portion of the housing assembly during administration.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates to a drug delivery device for delivering a fixed dose. In particular, the present invention relates to such a drug delivery device, which comprises a transmission mechanism having a helical guide portion and an axial guide portion. Background Art

[0002] Drug delivery devices for self-administration of different liquid drug formulations currently exist in various shapes and sizes. Some are suitable for connection to infusion devices, while some are connectable or integrated with injection needles. The latter is called an injection device. Some are durable devices including a barrel with a drug reservoir, wherein the barrel can be replaced. Others are disposable devices, which are discarded when the barrel is empty. Disposable devices can be multi-dose devices (wherein the user can set the desired dose size before each injection) or single-dose devices (which can only administer a single dose of a given size). The latter coexists with the so-called "shield activation", in which the sleeve is covered by a shield at the front of the device, which releases the dose when pressed. Then, when the user presses the device against the skin to depress the shield and release the dose, only the sleeve is exposed to enter the skin. These injection devices are discarded after a single injection.

[0003] Fixed dose devices are preferred for some users because they may not be comfortable with or able to operate the device to adjust the correct dose every time. For example, when a child or elderly person uses the device, simplicity and ease of use are very important in order to avoid user errors leading to over or under dosing. In other cases, the treatment regimen prescribes a fixed dose of a drug of the type, for example, GLP-1.

[0004] However, the device itself carries a significant portion of the cost of the unit, not to mention the amount of material used and therefore necessarily discarded. It is therefore desirable to produce a fixed-volume fixed dose device capable of delivering multiple doses.

[0005] In existing multi-dose devices, the motor includes a spring that is wound when the dose is adjusted. One solution is to make a normal multi-dose device in which the maximum dose size is limited so that only a fixed dose size can be dialed up. However, this will carry the risk of the user not dialing up sufficiently and thus obtaining a smaller dose than intended, a problem that has been addressed in WO2020089167 filed by Novo Nordisk, in which the ratchet tube is locked to the housing until the full dose has been set and the transmission mechanism has been released.

[0006] Another fixed dose device is disclosed in WO2019 / 09179 filed by Sanofi-Aventis. The disclosure relates to an injection device having a longitudinally displaceable dose tracker that provides automatic dose setting according to a preselected dose size. The disclosed injection device comprises: an elongated housing 10 extending along a longitudinal axis (z); a piston rod 20, 120, which is operatively engaged with a piston 7 of a barrel 6 filled with a medicament. The injection device also includes a dose tracker 60, 150, 250, 350, 450, 550, which is selectively operatively engageable with the piston rod 20, 120, wherein the dose tracker is proximally displaceable relative to the housing 10 from an initial position (i) (see Figure 25) toward at least a first activation position (a) (see Figure 26) for setting a dose, and wherein the dose tracker is distally displaceable relative to the housing (10) from the activation position (a) toward the initial position (i) for dispensing a dose. The injection device comprises a spring 80, 144 which pushes the dose tracker in the proximal direction. The injection device further comprises: an interlock 84, 184, 284, 584 which locks the dose tracker in the initial position (i); and a release member 100, 101, 190, 290, 590 for releasing the interlock 84, 184, 284. For example, if the release member 190 is activated to release or release the dose tracker 150, the dose tracker 150 begins to rotate relative to the housing under the action of relaxing the spring 144. An alternative fixed dose device is disclosed in WO 2017 / 106221 filed by Merch Sharp & Dohme Corp., in which the size of the fixed dose can be selected. However, making it possible to select between fixed doses of different sizes increases the complexity of the device, and the selection function is not always ideal. The function of providing different fixed dose sizes can alternatively be obtained with a set of two or more different fixed dose devices.

[0007] An alternative fixed dose device is disclosed in WO2018 / 007259 filed by Copernicus. The disclosure relates to an injection device for delivering a defined number of equal doses of a fluid substance. The disclosed injection device comprises: a housing 1 having an arming mechanism; and a dose delivery mechanism arranged along the longitudinal axis of the housing. The housing is coupled to an enclosure 3 for receiving a reservoir having a fluid substance. The arming mechanism comprises a setting sleeve 5, which is axially non-displaceable. The arming mechanism is rotatable in two opposite directions around the axis of the housing at a defined setting angle (a). The setting sleeve 5 is coupled to a torsion spring 10, which is tightened by the rotation of the setting sleeve 5 during the arming of the device. The dose delivery mechanism comprises a screw ring 6 and a piston rod 4, which is non-rotatable and axially displaceable in the setting sleeve 5. When the piston rod 4 cooperates with the screw ring 6 during the arming of the device, the screw ring 6 and the piston rod 4 are fixed. During the delivery of each dose, the piston rod 4 is displaced a defined distance along the housing 1 due to the unwinding of the spring 10 and the rotation of the screw ring 6. The displacement of the piston rod 4 causes the fluid substance to be discharged from the reservoir. As presented, in order to be able to eject the dose, the torsion spring must be tightened. An alternative design utilizing the compression of the spring is described in WO 2017 / 098460, also filed by Copernicus. Another alternative device that also utilizes the compression of the spring before each fixed dose is disclosed in WO94 / 26331 filed by Owen Mumford. However, it is not always ideal to equip the device between each dose because it requires the user to be able to provide sufficient force to equip the device.

[0008] An alternative fixed dose device is disclosed in WO2013 / 034651 filed by Menarini. The disclosure relates to a device for automatically injecting two doses of a medicament twice in succession. The disclosure describes an automatic injection device comprising a sliding sheath 30, which interacts with cam means 26, 27, 28 to activate the triggering of a plunger 8 when the front end 3 thereof is pressed against the injection site, thereby controlling the delivery of a dose of the drug. A plunger guide means 44 is provided on the inner surface of the outer shell 1 for controlling the triggering sequence, and a dose knob 4 is used to equip or set the device under dose delivery conditions. It is provided that the device is suitable for automatic needle re-sheathing after each dose is delivered and resetting of the locking condition. The reduced number of device components results in a simpler structure and reduced costs. Devices of the same applicant and having similar functions are disclosed in WO2013 / 034647 and WO2011 / 111006. As presented, all alternatives utilize a compression spring as a power means for driving the plunger.

[0009] Therefore, there remains a need for alternative delivery injection devices for delivering a predefined fixed dose that meets the need for a simple, safe, user-friendly and robust drug delivery device.

[0010] In view of the above, it is an object of the present invention to provide a user-friendly, safe and robust drug delivery device for delivering a fixed dose of medicament.Another object is to provide such a drug delivery device comprising a transmission mechanism having a helical guide portion and an axial guide portion. Summary of the invention

[0011] In the disclosure of the present invention, a plurality of embodiments and aspects will be described which will address one or more of the above-mentioned objects, or will address objects that will be apparent from the following disclosure and from the description of exemplary embodiments.

[0012] In a first aspect of the present disclosure there is provided a drug delivery device for delivering a fixed dose, wherein the drug delivery device comprises:

[0013] - housing assembly,

[0014] -Drug reservoir with piston

[0015] - a transmission mechanism, the transmission mechanism comprising: a piston rod operatively arranged in the housing assembly and adapted to advance the piston to expel the drug during administration; and a transmission tube operatively arranged together with the piston rod (109, 209), wherein the transmission tube (180, 280) is adapted to be axially movable relative to the housing assembly and prevented from rotating in a fixed state, and is adapted to be axially movable and rotatable relative to the housing in an administration state, wherein the transmission mechanism is adapted to deliver a predefined fixed dose in response to activation;

[0016] - an activation mechanism for activating the transmission mechanism in response to moving the transmission tube in an axial direction,

[0017] wherein the housing assembly comprises a guide structure for guiding the drive tube during activation and delivery of a dose, wherein the guide structure comprises: an axial portion providing a sliding surface, the sliding surface of the axial portion being used for guiding the drive tube during activation and for providing a rotational stop defining an end point of a dose position, and a circumferential portion providing a sliding surface, the sliding surface of the circumferential portion being suitable for guiding the drive tube during administration;

[0018] wherein the transmission tube comprises a guide structure comprising an axial portion adapted to slidably engage a corresponding axial portion of the housing assembly for activation; and a circumferential portion adapted to slidably engage a corresponding circumferential portion of the housing assembly during administration,

[0019] The transmission tube (180, 280) can thereby be guided along the axial portion (156, 256) without rotating, thereby being able to change from the fixed state to the dosing state during activation, whereby the transmission tube (180, 280) can be axially moved and rotated by the transmission mechanism in the dosing state, and whereby in response to activation of the transmission mechanism, the transmission tube (180, 280) can be guided along the circumferential portion (189, 289) to the end point of the dosage position, thereby changing from the dosing state to the fixed state.

[0020] A drug delivery device is provided herein, wherein the transmission mechanism comprises a helical guide portion and an axial guide portion to provide a fixed dose immediately upon activation.

[0021] In another aspect, the guide structure of the housing assembly is a closed guide that provides a duty cycle for the drive tube, and wherein the starting position of the drive tube and the end of the dose position are the same.

[0022] In this case, the transmission mechanism is suitable for providing a plurality of fixed doses using the same working cycle.

[0023] On the other hand, the circumferential portion (157, 257) of the guide structure of the housing assembly is a spiral portion (157, 257) or a stepped portion including at least one step, and wherein the corresponding circumferential portion (189, 289) of the guide portion of the transmission tube (180, 280) is a spiral portion (189, 289) corresponding to the spiral portion (157, 257) of the housing assembly or a stepped portion including at least one step corresponding to the stepped portion of the housing assembly.

[0024] In another aspect, the housing assembly further includes internal threads, wherein the piston rod includes external threads that engage the internal threads of the housing assembly.

[0025] Here, the piston rod is operatively arranged in the housing via a threaded connection.

[0026] In another aspect, the drive tube is axially splined to the piston rod, thereby allowing relative axial movement and preventing relative rotation, and thereby advancing the piston rod (109, 209) in response to rotation of the drive tube.

[0027] Here, the transmission tube is operatively arranged with the piston rod in a spline connection. The spline connection may include a key fit in a keyed manner.

[0028] In another aspect, the transmission mechanism further comprises a motor mechanism for rotating the transmission tube for delivering a dose in response to activation of the transmission mechanism, wherein the transmission tube is axially splined to the piston rod, whereby the transmission tube is axially movable and rotationally locked relative to the piston rod, wherein the transmission mechanism further comprises a return mechanism for moving the transmission tube in an axial direction after activation, thereby returning the transmission tube.

[0029] On the other hand, the trigger mechanism includes a movably arranged connector, wherein the connector includes an activation tab, and wherein the activation tab is adapted to engage a surface portion of the transmission tube in response to moving the connector in an axial direction, whereby the connector is operatively connected to the transmission mechanism and adapted to trigger the transmission mechanism, wherein the surface portion is oriented in a direction toward the activation tab.

[0030] Here, the activation tab can abut the surface portion of the transmission tube during activation.

[0031] On the other hand, the fixed state includes: the transmission tube can be arranged in the original position, wherein the transmission tube can be arranged in a first axial position, wherein the transmission tube is allowed to move in one axial direction and is blocked by the housing in another axial direction; and arranged in a first angular position, wherein the transmission tube is prevented from rotating in one direction by the housing and is constrained by the transmission mechanism in another rotational direction, wherein the guide structure of the transmission tube abuts the axial portion of the housing assembly and the spiral portion of the guide structure of the housing assembly; wherein the administration state includes:

[0032] the transmission tube is arrangable in a first dosing position, wherein the transmission tube is arrangable in a second axial position and in the first angular position, whereby the transmission mechanism is activated, and

[0033] - a second dosing position, wherein the transmission tube is arrangeable in an axial position between the first axial position and the second axial position, and in an angular position different from the first angular position, wherein the helical portion of the guide structure is slidably arranged along the helical portion of the guide structure of the housing assembly, thereby enabling the expulsion of a dose.

[0034] On the other hand, in response to moving the connector from a first axial position to a second axial position, the connector is suitable for moving the transmission tube between the first axial position and the second axial position, thereby changing the position of the transmission tube (180, 280) from the original position to the first dosing position, and wherein in response to activating the transmission mechanism by setting the transmission tube in the first dosing position, the transmission mechanism is suitable for rotating the transmission tube, thereby changing the position of the transmission tube from the first dosing position to the second dosing position and the original position.

[0035] In another aspect, the first position and the second position of the connector are different than the first position and the second position of the transmission tube.

[0036] In another aspect, an axial distance between the first position and the second position of the connector is greater than or equal to an axial distance between the first position and the second position of the transmission tube.

[0037] On the other hand, the motor mechanism includes a torsion transmission spring, which is used to rotate the transmission tube by unwinding, wherein the transmission spring is fixed between the housing assembly and the transmission tube, and wherein the transmission spring is also compressible for axially moving the transmission tube during rotation, whereby the transmission spring provides the return mechanism for returning the transmission tube after activation.

[0038] In another aspect, the drive spring includes a compressible section.

[0039] On the other hand, the activation tab of the connector includes a lateral surface portion, and wherein the engageable surface portion of the transmission tube is lateral, thereby enabling initiation of drug delivery by rotational movement caused by the torsion transmission spring in response to activation of the transmission mechanism.

[0040] In another aspect, the drug delivery device comprises a spring base rotatably arranged relative to the housing assembly, wherein a one-way ratchet mechanism is provided between the rotatably arranged spring base and the housing assembly, whereby the spring can be tightened by rotating the spring base.

[0041] In another or alternative aspect, the motor mechanism includes a compression drive spring, wherein the activation tab includes a helical surface portion, wherein the engageable surface portion of the drive tube for activating the drive tube includes a helical surface portion, wherein the activation tab is adapted to cause an initial rotation of the drive tube in the dosing direction in response to engaging the tab and resisting the biasing force of the compression spring and moving the drive tube between the distal position and the proximal position, and wherein the helical portion of the housing assembly and the compression spring are adapted to provide further rotation of the drive tube in response to the initial rotation, thereby enabling delivery of a complete fixed dose.

[0042] In another aspect, the piston rod comprises an axially extending track, wherein the drive tube comprises an inward protrusion adapted to slidably engage the axial track, whereby the drive tube is rotationally locked relative to the piston rod.

[0043] In another embodiment, the axial portion and the helical portion of the guide structure of the housing are respectively an axial surface portion and a helical surface portion, and wherein the axial portion and the helical portion of the guide structure of the transmission tube are respectively an axial surface portion and a helical surface portion.

[0044] In another aspect, movement of the connector from the first axial position to the second axial position is a purely axial movement.

[0045] In another aspect, the first axial position is a distal position and the second axial position is a proximal position.

[0046] In another aspect, the drug delivery device is an injection device.

[0047] In another aspect, the drug delivery device further comprises a shield for operating the connector, wherein the shield is adapted to cover a portion of the needle cannula in a distal position and to expose the needle cannula in a proximal position, wherein the needle is insertable into a subject with the shield in the proximal position, and wherein in response to moving the shield from the distal position to the proximal position, the shield is adapted to move the connector between the first axial position and the second axial position, wherein the first position and the second position of the connector are a distal position and a proximal position.

[0048] In another or alternative aspect, the piston rod is axially splined to the housing assembly, whereby the piston rod is axially movable and rotationally locked relative to the housing assembly, wherein the transmission tube further comprises an internal thread, whereby the piston rod is operatively arranged in the housing assembly, wherein the piston rod further comprises an external thread, the external thread being used to threadably engage the internal thread of the transmission tube, whereby the piston rod is operatively arranged with the housing assembly and the transmission tube, and wherein the piston rod is advanced during rotation of the transmission tube, wherein the transmission mechanism comprises a motor mechanism, the motor mechanism comprising a compression transmission spring, the compression transmission spring being used to axially move the transmission tube and the piston,

[0049] wherein the drug delivery device further comprises a connector having an inclined activation tab adapted to engage an inclined surface of the drive tube and to initially rotate the drive tube in the drug delivery direction in response to engagement between the activation tab and the drive tube against the biasing force of the compression drive spring,

[0050] wherein the fixed state includes the drive tube being arrangable in: a home position, wherein the drive tube is arrangable in a first axial position, wherein the drive tube is permitted to move in one axial direction and is blocked by the housing in another axial direction; and a first angular position, wherein the drive tube is blocked from rotation in one direction by the housing and is constrained by the drive mechanism in another rotational direction, wherein the guide structure of the drive tube abuts the axial portion of the housing assembly and the helical portion of the guide structure of the housing assembly;

[0051] The administration status includes:

[0052] - the transmission tube is arrangable in a first dosing position, wherein the transmission tube is arrangable in a second axial position and in the first angular position, wherein the activation tab engages the transmission tube against the biasing force of the compression transmission spring, thereby activating the transmission mechanism, and

[0053] a second dosing position, wherein the transmission tube can be arranged in an axial position between the first axial position and the second axial position and in an angular position different from the first angular position, wherein the spiral portion (189, 289) of the guide structure can be slidably arranged at any position along the spiral portion (157, 257) of the guide structure of the housing assembly, thereby enabling the discharge of a dose

[0054] When the position of the transmission tube changes from the original position to the first drug delivery position, the transmission tube and the piston move together.

[0055] wherein the transmission tube is rotatable relative to the piston rod in response to a change in the angular position of the transmission tube from the first dosing position to the second dosing position, wherein the change in angular position relative to the housing is caused by the helical guide surface of the housing and the compression transmission spring,

[0056] wherein the transmission tube is simultaneously movable together with the piston rod in response to the axial position of the transmission tube changing from the first dosing position to the home position, wherein the change in axial position relative to the housing is caused by the helical guide surface of the housing and the compression transmission spring,

[0057] Thereby in response to activation of the transmission mechanism, a fixed dose has been delivered when the transmission tube has returned to the home position. BRIEF DESCRIPTION OF THE DRAWINGS

[0058] The following embodiments of the present invention will be described with reference to the accompanying drawings, in which:

[0059] Figure 1A An exploded view of an injection device according to a first embodiment of the present disclosure is shown.

[0060] Figure 1B Shows Figure 1A Detail of the cartridge holder of the illustrated embodiment.

[0061] Figure 1C Shows Figure 1A Details of the shield rear portion and movable portion of the cleaning assembly of the illustrated embodiment. Figure 1C In window W1 , the structures are shown in black and white and in grayscale, with the piston being separated from the chamber.

[0062] Figures 1D to 1F Shows Figure 1A Details of the shield rear portion, cannula, needle hub and cartridge engagement structure of the cleaning assembly of the illustrated embodiment. Figure 1F , window W2 shows the assembly in grey scale, and W3 shows a cross section of the seat in grey scale to reveal the guides on the inner surface.

[0063] FIG. 2A to FIG. 2D Shows Figure 1A Further details of the cleaning assembly of the illustrated embodiment. Figure 2B , Figure 2C and Figure 2D The structures are shown in black and white and in greyscale in windows W4, W5 and W6 respectively to improve the assessability of gaps, inclined surfaces and separated parts. Window W6 is angled to show the slit in the seat.

[0064] FIG. 3A to FIG. 3F Shows Figure 1ADetail of the guide structure of the elongated housing structure of the embodiment shown.

[0065] Figure 4A and Figure 4B Shows Figure 1A Detail of the zero adjustment nut of the embodiment shown.

[0066] Figure 5 Shows the settings in Figure 1A Further details of the zero adjustment mechanism on the elongated housing structure of the illustrated embodiment.

[0067] Figure 6 Shows Figure 1A A cross-sectional view of the proximal portion of an injection device of an embodiment of the present invention. The injection device shown includes a piston gasket.

[0068] Figure 7 Shows Figure 1A Detail of the piston rod of the embodiment shown.

[0069] FIG. 8A to FIG. 8B Shows Figure 1A Detail of the drive tube of the embodiment shown.

[0070] FIG. 9A to FIG. 9B Shows Figure 1A Detail of the housing insert portion of the embodiment shown.

[0071] FIG. 10A to FIG. 10C Shows Figure 1A Detail of the elongated shield structure of the illustrated embodiment.

[0072] FIG. 11A to FIG. 11B Shows Figure 1A Details of the connector of the embodiment shown.

[0073] FIG. 12A to FIG. 12B The proximal end of the injection device is shown in cross-sectional views from two different angles. Figure 1A The embodiments shown are identical.

[0074] FIG. 13A to FIG. 13D Shows Figure 1A Details of the transmission mechanism of the embodiment shown.

[0075] FIG. 14A to FIG. 14B The cross-sectional view of the entire injection device from two different angles is shown. Figure 1A The embodiments shown are identical.

[0076] FIG. 15A to FIG. 15B Shown in Figure 1A User operations and status during operation of the injection device. Fig.15AAn operation for taking a first fixed dose is shown, and Fig. 15B Subsequent doses are shown.

[0077] 16A to 16T Shows the Figure 1A An injection device is provided, thereby providing a detailed illustration of the operation of the device.

[0078] Fig.17 An exploded view of an injection device according to a second embodiment of the present disclosure is shown.

[0079] Fig.18 Shows Fig.17 Detail of a cross-sectional view of the embodiment shown.

[0080] Fig.19 Shows Fig.17 Detail of the housing of the embodiment shown.

[0081] Fig. 20 Shows Fig.17 Detail of the inner tubular portion of the housing of the embodiment shown.

[0082] Fig.21 Shows Fig.17 Detail of the relocking tube of the embodiment shown.

[0083] Fig. 22 Shows Fig.17 Details of the connector of the embodiment shown.

[0084] FIG. 23A to FIG. 23B Shows Fig.17 Detail of the drive tube of the embodiment shown.

[0085] Fig.24 Shows Fig.17 Detail of the elongated shield structure of the illustrated embodiment.

[0086] FIG. 15A to FIG. 15B Shown in Figure 1A User operations and status during operation of the injection device. Fig.15A An operation for taking a first fixed dose is shown, and Fig. 15B Subsequent doses are shown.

[0087] Figures 25A to 25G show the Fig.17 An injection device is provided, thereby providing a detailed illustration of the operation of the device during a first dose.

[0088] 26A-26B show the following dosage period in different states and intermediate arrangements. Fig.17 injection device.

[0089] In the accompanying drawings, similar structures are primarily identified by similar reference numerals. Reference numerals followed by the letter "a" are used to indicate the distal end of a structure, while reference numerals followed by "b" are used to indicate the proximal end. Reference numerals comprising a first reference numeral followed by a "." and a second reference numeral are used to indicate the function or structural detail of a structure. In this way, a first reference numeral indicates a primary (relatively large) structure, while a second reference numeral indicates a secondary (relatively small) structure or a specific function. Reference numerals followed by the letters c, d, and e indicate features having rotational symmetry. DETAILED DESCRIPTION

[0090] When the following terms such as "upper" and "lower", "right" and "left", "horizontal" and "vertical" or similar relative expressions are used, these terms are only with reference to the drawings and not necessarily to the actual context of use. The drawings shown are schematic representations and therefore the configuration of the different structures as well as their relative sizes are for illustrative purposes only. When the term "member" is used for a given component, it can be used to define a single component or a part of a component having one or more functions.

[0091] In the detailed description below, more specific details are set forth to provide a more thorough understanding of the present disclosure. However, it will be apparent to one of ordinary skill in the art that the present disclosure may be practiced without these specific details. In other cases, well-known methods, processes, components, circuits, and networks are not described in detail to avoid unnecessarily obscuring aspects of the embodiments.

[0092] It should also be understood that, although the terms first, second, etc. can be used in this article to describe various elements, these elements should not be limited by these terms. These terms are only used to distinguish an element from another element. For example, without departing from the scope of the present disclosure, the first subject can be referred to as the second subject, and similarly, the second subject can be referred to as the first subject. The first subject and the second subject are both subjects, but they are not the same subject. In addition, the terms "subject", "user" and "patient" are used interchangeably in this article.

[0093] As used herein, the term "if" may be interpreted to mean "when" or "after" or "in response to determining" or "in response to detecting," depending on the context. Similarly, the phrases "if it is determined" or "if [stated condition or event] is detected" may be interpreted to mean "after determining" or "in response to determining" or "after detecting [stated condition or event]" or "in response to detecting [stated condition or event]," depending on the context.

[0094] As used herein, the terms "distal end" and "proximal end" are analogous to anatomical terms used to describe the ends that are distal or closest to the body attachment point. Thus, the distal end of an injection device is defined in the context of a user holding the device in an injection-ready position, whereby the end with the injection needle would be the distal end and the opposite end would be the proximal end. Furthermore, the distal and proximal ends of various components of the device are also defined in this context.

[0095] As used herein, the trailing edge and the leading edge are used to describe the edge of a structure that moves relative to another structure. The leading edge is the edge in the direction of movement, while the trailing edge is the opposite. In this way, the leading edge and the trailing edge are defined according to the relative direction of movement between the structures.

[0096] As used herein, rotational symmetry is the property of a structure to appear the same or to have the same function after a number of rotations of less than one turn. The degree of rotational symmetry of a structure is the number of different orientations in which the structure appears the same for each rotation. Rotational symmetry of order n (where n is 2 or greater) is also referred to as n-fold rotational symmetry or nth degree rotational symmetry with respect to a particular point (in 2D) or axis (in 3D). 阶 The discrete rotational symmetry of a structure means that rotation through an angle of 360° / n does not change the object. The properties of a structure can relate to both the visible appearance and the functional capabilities of the structural features.

[0097] As used herein, the term "clockwise direction" is used to describe the direction of rotation of the needle of a clock as viewed from the front. Thus, clockwise rotation of the injection device is clockwise rotation observed when the device is viewed from the front of the distal end. Counterclockwise or anti-clockwise rotation is defined as the opposite direction.

[0098] As used herein, a proximal face is a face of a device as viewed from the proximal end and in a distal direction, wherein a distal face is a face of a device as viewed from the distal end and in a proximal direction.

[0099] As used herein, the positive axial or longitudinal direction is defined from the proximal end toward the distal end. The positive axial direction and the distal direction are used interchangeably with the same meaning. Similarly, the definitions of the negative axial direction and the proximal direction are used interchangeably with the same meaning. The central axis of the device is defined as passing through the center of the injection device in the positive axial direction, which is also referred to as the longitudinal axis with the same meaning.

[0100] As used herein, a positive radial direction is defined as being along a radial axis originating from the central axis and having a direction perpendicular to the central axis.

[0101] A positive circumferential direction or positive angular direction is defined for a point located at a radial distance from the central axis, wherein the circumferential direction is counterclockwise and perpendicular to the axial direction and the radial direction. As used in the present disclosure, directions may be positive and negative. For example, the term "axial direction" covers a positive axial direction from the proximal end toward the distal end and a negative axial direction in the opposite direction.

[0102] Both radial and circumferential directions are referred to herein as transverse directions, as they are transversely perpendicular to the axial direction. A transverse plane is defined herein as the plane spanned by two vectors in the radial and circumferential directions for a given coordinate along the axis and with the central axis as normal vector.

[0103] As used herein, axial movement of a structure is used to describe movement in which the displacement vector of the structure has a component in the axial direction. Translational movement is used to describe uniform movement in the axial direction only. Pure, strict, or uniform axial movement is the same as translational movement, and the terms are used interchangeably.

[0104] Radial movement of a structure is used to describe movement in which the displacement vector of the structure has a component in the radial direction. Pure or strictly radial movement is used to describe uniform motion in the radial direction only. Therefore, pure, strict, and uniform radial movement are the same, and the terms are used interchangeably.

[0105] Circumferential movement, angular movement or rotational movement of a structure is used to describe such movement, in which the displacement vector of the structure has a component in the circumferential direction. Pure or strictly circumferential movement is used to describe uniform movement only in the circumferential direction. Therefore, pure, strict and uniform circumferential movement is the same as pure, strict and uniform angular movement or rotational movement, and these terms can be used interchangeably. The definition of rotational movement of a structure also covers such special cases, in which the structure includes a central axis that defines the axis of rotation. In this special case, all positions of the structure outside the central axis are subjected to circular motion, and the displacement vector of the positions on the central axis is zero. Therefore, a structure that rotates around its own central axis and moves in the axial direction is said to perform rotational movement.

[0106] Helical movement of a structure is used to describe a combined axial and angular or rotational movement, wherein the displacement vector of the structure comprises a circumferential component and an axial component. The definition of helical movement of a structure also covers the special case where the structure comprises a central axis defining the axis of rotation. In this special case, all positions of the structure outside the central axis undergo helical movement, while the displacement vectors of positions on the central axis comprise only an axial component. Thus, a structure that rotates about its own central axis and moves in the axial direction is said to perform a helical movement.

[0107] In this context, pure, strict, and uniform motion are abstract mathematical definitions, and these terms are used to describe the ideal or abstract motion of a device. Therefore, structures in actual devices should not be expected to exhibit this ideal behavior, but rather should be expected to move in a pattern that approximates this ideal motion.

[0108] As used herein, a right-hand thread or helical portion is a thread or helical portion whose helix moves in the positive axial direction when the threaded member is turned clockwise. Threaded members with right-hand threads are conventionally the default threads and are screwed in the positive axial direction by counterclockwise rotation, which is usually performed with the right hand. Similarly, threaded members with left-hand threads are screwed in the positive axial direction by clockwise rotation and can therefore be performed with the left hand and in a mirror image of the right-hand action that operates a right-hand thread.

[0109] Embodiments of the present disclosure are described in detail with respect to an injection device adapted to provide multiple fixed doses. However, the injection device may also be adapted to provide only one predefined fixed dose, wherein the volume of the drug is defined by a transmission mechanism comprising the number of revolutions per unit dose and the diametral pitch thread of the piston rod.

[0110] Embodiments of the present disclosure are described in detail with respect to an injection device comprising a reusable integrated needle cannula with a clean chamber, wherein the injection device is suitable for providing a plurality of predefined fixed doses. However, in an alternative embodiment, a needle cartridge as described in EP20157959.6, entitled “an injection device with integrated needles” filed by Novo Nordisk, may be integrated instead of a single reusable needle.

[0111] First embodiment

[0112] 1 to 16 illustrate a first embodiment of an injection device for delivering multiple fixed doses according to the present disclosure. Figure 1A An exploded view of such an injection device is shown. Figure 1B Figures 14 to 14 show further details of the various structures and mechanisms. Fig.15A and Fig. 15B A series of states during use of the injection device 100 is shown in perspective, showing the user operation from receiving the device, activating the device and delivering the multiple fixed doses. FIG. 16 shows in detail the interrelationship of the mechanical structures during operation. As used herein, a state defines a certain arrangement or configuration of the device, and the state and operation provide a framework for explaining the principles of the device.

[0113] Figure 1A The cap 105, the shield tip 119, the shield rear portion 120.1 of the cleaning module 120 (see Figure 2B), a needle hub 125 having a needle cannula 124, a housing insert portion 160, a tubular elongated needle shield structure 110, a cartridge holder 130, a cartridge 135, a tubular elongated housing structure 140, a connector 170, a shield return spring 107, a transmission tube 180, a dose transmission spring 108, a piston rod 109, and a spring base 165.

[0114] Housing components

[0115] The injection device includes a housing assembly that provides a rigid frame and has guides and connectors for guiding and connecting other components of the device. The housing assembly includes a housing insert portion 160, a tubular elongated housing structure 140, a barrel holder 130, and a spring base 165. After final assembly, these structures are fixedly connected, and the housing assembly can provide a reference frame for describing the relative motion and position of other structures. The elongated housing structure 140 includes an internal thread that is used to engage the external thread of the piston rod. The internal thread can be provided in the form of an integral nut member that is rotationally and axially fixed to the housing structure 140. In one example, the nut member is an integral part of the housing structure 140. Alternatively, the nut member can be a separate part that is fixed to the housing during the assembly of the injection device, for example, by gluing or welding. The nut member is provided with an internal thread on the inner surface, which engages with the external thread of the piston rod 109 so that when the piston rod rotates relative to the housing structure, the piston rod is moved spirally. Alternatively, the internal thread is directly arranged in the housing. The housing insert portion 160 includes a cap catch at the end of the track for coupling with the cap bayonet. The housing insert portion 160 also includes a proximal edge for guiding the shield. For further description, the housing assembly may be referred to simply as the housing, and the needle shield assembly may be referred to simply as the needle shield.

[0116] The injection device 100 comprises a transmission mechanism and a trigger or activation mechanism. The transmission mechanism comprises a piston rod 109, a transmission spring 108 and a transmission tube 180, and these structures are operatively arranged in the housing for expelling a dose. The trigger mechanism comprises an elongated shield structure 110 and a connector 170, and these structures are operatively arranged in the housing for triggering the dose expelling mechanism.

[0117] Needle Shield Assembly

[0118] The injection device further comprises a needle shield assembly comprising a shield tip 119 and an elongated shield structure 110. The elongated shield structure 110 comprises a window 111 for inspecting the drug, the elongated shield being arrangable in a first position overlapping with the cartridge holder window 131 and in a second position without overlap, wherein a solid portion of the elongated shield structure covers the window 131 in the second position.

[0119] Cartridge holder

[0120] The cartridge holder 130 is adapted to receive a cartridge 135. The cartridge holder includes a window 131 for inspecting the drug in the cartridge 135. Figure 1B The cartridge holder 130 is shown from the side and includes an axial rib 132 for axially guiding the needle hub, a flexible arm for snapping onto a neck portion 137 of the cartridge ( Figure 1A ); and a proximal extension tab 130.1 for aligning and positioning the cartridge when inserted into the housing during assembly. A circumferentially extending flange 134 ( Figure 1A ), after assembly and in the initial unpacked state, the circumferentially extending flange provides a small axial clearance for the distal end surface of the barrel.

[0121] cylinder

[0122] like Figure 1A As further shown, the elongated barrel 135 comprises a distal end 135a sealed by a pierceable septum and an open proximal end 135b closed by a piston. The piston is not shown in FIG. 1. The barrel comprises a reservoir containing the plurality of fixed doses of the medicament. A septum covered by a cap is provided at the distal end 135a. The cap and the main part of the reservoir are separated by a neck portion 137.

[0123] Needle Assembly

[0124] The injection device further comprises a needle assembly comprising a needle hub 125 and a reusable needle cannula 124. The cannula comprises a proximal end for piercing the pierceable septum and for establishing fluid communication with the reservoir, and a distal end for insertion into the skin of a subject or user of the device.

[0125] Piston gasket

[0126] A piston washer (although not shown in FIG. 1 ) can be connected to the piston rod to provide a pressure foot for contacting the piston. Alternatively, a dose measurement module for measuring the relative rotation between the piston rod and the piston can be provided between the piston rod and the piston. Such a measurement module also provides a suitable pressure foot. Such a dose measurement module is described in WO 20141128155 entitled “Dosecapturing cartridge module for drug delivery device”. Alternatively, the piston rod directly contacts the piston.

[0127] Blocked Shots

[0128] The cap 105 is adapted to be releasably mounted to the housing insert portion 160. The cap comprises an inner surface ( Fig.16F), which is adapted to be guided by an axial and circumferential cap mounting track 161, which will be described in detail later in this application. The protrusion is also adapted to cooperate with a snap lock 161.1 to releasably lock the cap 105 to the inner housing part 160. The cap is adapted to be installed and removed by sequential axial and rotational movement to provide a bayonet coupling associated with an injection device. The inner surface of the cap 105 also includes an axially extending rib 105.1 ( Fig.16A ), the axially extending ribs protrude from the inner surface and the cap is adapted to transfer torque to the shield structure 110 through the axially extending ribs 116 on the outer surface of the shield, as will be referred to later Fig.16A Explained.

[0129] Spring base

[0130] The spring base 165 is fixedly mounted to the housing structure 140 at the proximal end and is adapted to receive and support the compressible torsion transmission spring 108 .

[0131] Transmission spring

[0132] The transmission spring 108 is pre-tensioned or coiled and is positioned between the spring base and the transmission tube 180. The transmission spring is also adapted to induce a torque on the transmission tube, thereby enabling the expulsion of the medicament. The transmission spring comprises torsion sections 108.3, 108.4, wherein the spacing between the coils is relatively small, and the compressible section 108.4 is adapted to transmit an axial force to the transmission tube after compression and during the expulsion of the medicament. The ability to drive the transmission tube in the axial direction enables the end point of the dose mechanism and enables the resetting of the transmission tube.

[0133] Return spring

[0134] The connector return spring 107 is positioned between the spring base 165 and the connector 170 and is adapted to urge the connector in the distal direction.

[0135] Cleaning components

[0136] Cleaning the needle between injections allows the same integrated needle to be used multiple times in a clean condition. Therefore, in an alternative embodiment of the present disclosure, the injection device includes a cleaning assembly 120, such as Figure 2BAs shown. The movable shielding member structure 110 is fixedly connected to the cleaning assembly 120 via the shielding member rear portion 120.1, and the principle of the cleaning module is disclosed in more detail in WO2019 / 101670. The cleaning assembly 120 includes a cleaning agent that keeps the distal end of the needle cannula 124 clean between injections. The shielding member rear portion 120.1 of the cleaning module is fixedly connected to the shielding member tip 119, which is in turn fixedly connected to the movably arranged elongated needle shielding member structure 110. The shielding member tip 119 can be plugged and adapted to the needle shielding member structure 110 via the elastic arm 119.1 that engages the elongated shielding member structure 110, so that the cleaning chamber assembly 120 follows the axial and rotational movement of the movably arranged shielding member structure 110. The shielding member structure 110 connected to the cleaning assembly 120 is movably arranged relative to the needle cannula 124 fixed to the housing.

[0137] The cleaning assembly 120 preferably includes a chamber with a liquid cleaning agent, which in one example can be the same preservative contained in the liquid drug in the barrel 135. In a preferred example, the cleaning agent is the same preservative containing the medicinal liquid drug contained in the barrel 135, which is filled into the chamber of the cleaning module during the start-up of the injection device. In an alternative embodiment, the cleaning agent is embedded in the porous plug. In another alternative, the cleaning agent is embedded in the matrix of the solid plug.

[0138] The shield can be arranged in different positions. The initial position is defined by an initial angular position and a corresponding initial axial position. The locked position is defined by a locked angular position and a corresponding locked axial position. The unlocked distal position is defined by an unlocked angular position and a corresponding distal unlocked axial position. The movable shield can be changed from the initial position to a locked position by a combined rotation and proximal movement, wherein the shield is axially locked. In both positions, the needle tip is covered by the shield and contained in the clean room assembly. During use, the shield can be further rotated and further moved in the proximal direction to the unlocked distal position, whereby the tip is covered. By further moving the shield in the proximal direction, the shield exposes a larger portion of the needle and enables injection. After the injection, the shield is moved back to the locked position, whereby the needle tip is cleaned.

[0139] If for some reason it would be desirable to reuse the needle without cleaning it, the cleaning module may be omitted.

[0140] Return to the illustrated embodiment 100 . Figure 1B There is shown a perspective view of the cartridge holder 130 having a proximally extending tab 130 . 1 for aligning and positioning the cartridge holder 130 relative to the housing 140 when inserted into the housing during assembly. Figure 1CAn exploded view of a cleaning module 120 is shown, comprising a shield rear portion 120.1 and a movable portion 120.2, the movable portion comprising a piston 122 and a piston rod 123, the piston rod having a radially extending arm 123.1 for cooperating with a needle seat 125 and the shield rear portion 120.1. The radially extending arm 123.1 comprises: a chamber housing engagement surface 123.2 for engaging the clean chamber 120; and a seat engagement portion 123.3 for engaging the seat 125. The needle rear portion 120.1 comprises a clean chamber housing 121, which comprises a distal tubular portion, an intermediate tubular portion and a proximal tubular portion. These portions are integrally connected. A cap is provided at the distal end of the distal tubular portion, which cap covers the distal diaphragm on the clean chamber housing. On the outer surface of the intermediate tubular portion are provided: a shield tab 121.1 for snapping onto the shield tip 119; and a seat push tab 121.2. Figure 1C Window W1 of FIG. 1 shows the same components in grayscale to better illustrate the inclined surfaces and the void portions. Figure 2B As shown, an inclined proximal surface guide 121.3 is provided at the proximal end of the clean room housing 121, which is used to guide the piston rod 123 and the piston 122 in the proximal direction in response to rotation. The window W3 in the figure supports the understanding of the mechanism for guiding or pushing the piston rod in the proximal direction. Rotating the piston rod 123 releases the static friction, and by further rotating it and pushing it into the inclined surface 121.3 of the clean room, a first well-defined axial movement will be provided. Figure 2D A cleanser reservoir 121.4 is shown in FIG. 1 , which is used to close the distal end of the needle cannula in a sterile condition before use and in a clean condition during use.

[0141] Figure 1D The relative positioning of the needle cannula 124, the movable part 120.2 of the clean room including the piston 122 and the piston rod 122, and the barrel engagement structure including the rigid part 126 and the soft inner plug (not shown in the figure) is shown in a perspective view. The soft inner plug can be made of rubber and is suitable for closing the proximal end of the needle cannula in a sterile initial condition before use. The rigid part 126 provides support for the soft inner plug and is suitable for moving the barrel in the proximal direction when the needle has established a fluid connection with the drug in the reservoir and in response to the seat 125 moving in the proximal direction. The soft plug can be penetrated by the proximal sharp end of the needle cannula. The rigid part 126 includes a radially extending seat engagement tab 126.1 and a radially extending barrel engagement tab 126.2. The rigid part also includes a distally extending blocking portion 126.3, which is used to block further axial movement of the seat when the seat is in the proximal position. As shown in Figure 2DAs seen above, the blocking portion 126.3 is adapted to engage a small indentation or circumferential slit 125.7 in the seat after a small relative rotation. The rigid portion 126 includes a proximal surface at the proximal end 126b that abuts the distal surface of the barrel after assembly. Thus, proximal movement of the rigid portion 126 of the barrel engagement structure provides proximal movement of the barrel.

[0142] Figure 1E A perspective view of a needle hub 125 is shown. The hub 125 includes a central circular disk portion 125.9 and a proximally extending skirt portion 125.11 extending from the disk portion. The skirt portion 125.11 is adapted to enclose the distal end of a barrel 135 and a barrel engaging structure including a rigid portion 126. The needle hub 125 also includes an axially extending finger 125.1 extending from the proximal end of the skirt portion 125.11 and adapted to cooperate with the axially extending rib 132 of the barrel retainer to allow relative axial movement between the hub and the barrel retainer and to prevent relative rotational movement. Extending from the distal end surface of the central disk portion 125.9 are two axial tube portions (annular sections that curve like a tube but do not extend 360 degrees in the circumferential direction) or flanges 125.12 that connect a tubular portion 125.13 to the central portion 125.9. The tubular portion is adapted to surround the cleaning assembly 120. As shown in Figure 2D As best seen above, a glue turret 125.10 for securing the needle cannula is centrally disposed on the central disk portion 125.9. The seat 125 further comprises a track disposed in the skirt portion 125.11 and adapted to guide the rotational movement of the barrel engagement structure. The track comprises a proximal axial portion 125.2 providing an initial seat for a seat engagement tab 126.1 of the barrel engagement structure, and a helical portion 125.3 for rotating the tab 126.1 and thereby the rigid portion 126 of the barrel engagement structure in response to guided proximal movement of the needle seat 125. The track further comprises a distal axial portion 125.4 adapted to allow or guide relative axial movement of the tab 126.1 and thereby the rigid portion 126 of the barrel engagement structure at the end of the rotation. A rib 128 is disposed on the inner surface of the axially extending flange 125.12 and projects in the negative radial direction, i.e. towards the center of the seat 125. The rib 128 includes an axially extending surface 128.1 that is flush with the edge of the flange 125.12. The axially extending surface 128.1 provides a rotational stop for engaging the piston rod 123. A circumferentially extending surface 128.2 is also provided at the distal end of the rib 128 (see also Figure 1F Window W3 and Figure 2D ). The circumferentially extending surface 128.2 provides an axial stop for engaging the push tab 121.2 of the chamber housing.

[0143] Figure 1F Shows Figure 1DThe components of the module shown, where Figure 1E The seat 125 is shown in an unpacked state, which is the initial state and before fluid connection is established between the needle cannula and the reservoir of the barrel 135. It should be noted that an axial gap is provided between the blocking portion 126.3 and the proximal surface of the central portion 125.9, which gap allows relative axial movement between the seat 125 and the rigid portion 126 of the barrel engagement structure adjacent to the barrel 135. Therefore, the gap allows the needle cannula to be inserted into the barrel in response to the relative axial movement. Window W2 shows the entire assembly in black and white and in grayscale. Window W3 shows the inner surface of the needle seat 125 and the guide 128 having surfaces 128.1 and 128.2.

[0144] Figure 2A A perspective view of a clean chamber housing 121 positioned in a needle seat 125 in an unpacked state is shown. In a first angular position, the tubular portion 125.13 surrounds the proximal portion of the clean chamber housing, and the radially extending seat push tab 121.2 rests on the distal support surface 127 of the seat. As explained in detail later in this application, the needle guard is adapted to be guided immediately upon initialization to perform a proximal spiral motion. When the clean chamber housing is fixed to the needle shield, the push tab 121.2 performs a proximal spiral motion relative to the rotationally fixed needle seat in response to initialization. The needle seat is axially movable between a distal position and a proximal position. When the needle seat is axially movably positioned on the barrel holder 130, in response to the needle shield moving from the initial position to the locked position, the push tab 121.2 of the chamber housing forces the needle seat from the distal position to the proximal position. In addition, during the axial movement of the shield, the push tab 121.2 has also been rotated from the initial angular position to the locked angular position together with the shield. In the locked angular position, the push tab 121.2 is angularly aligned with the cutout 125.5 in the tubular portion 125.13 of the needle hub and it is aligned with the axial stop surface 128.2. An axial gap is provided between the push tab 125.2 and the axial stop surface 128.2. Between the initial angular position of the shield and the locked angular position, the hub has been moved a certain proximal distance to connect the proximal end of the needle cannula 124 with the reservoir of the barrel 135. The proximal movement of the hub has also provided a rotation of the barrel engagement structure, whereby the tab 126.2 having the cam surface has been rotated and forced into the axial gap between the distal surface of the barrel distal end and the proximal surface of the circumferentially extending flange 134 (see FIG. 1 ). Figure 1A). Therefore, the axial clearance between the barrel and the circumferential flange 134 has become larger, and the barrel has been pushed relative to the barrel in the proximal direction, and the neck engagement arm 133 has deflected. In the locked position of the shield corresponding to the proximal position of the seat 125, contact has been established between the blocking portion 126.3 of the barrel engagement structure and the central seat portion 125.9. In this position, the clean room housing can move proximally until it abuts the stopper surface 128.2. For the shield and the shield rear portion 120.1 to be in the locked position, the shield rear portion is suitable for moving to the distal unlocked position with the shield in another proximal spiral movement. For the shield and the shield rear portion 120.1 to be in the distal unlocked position, the shield and the shield rear portion can further move in a strict proximal direction to deliver a dose through the needle.

[0145] Figure 2B A perspective view of a clean room piston rod 123 arranged in a clean room housing 121 is shown. As shown, an inclined surface 121.3 at the proximal surface of the chamber housing 121 is axially aligned with an axially extending surface 123.2 of the piston rod. In this initial position, the surface 123.3 of the piston rod is arranged to abut against a rotation stop 128.1 of a seat 125, and therefore cannot move in a counterclockwise direction relative to the seat. Initially, a circumferential gap is provided between the inclined surface 121.3 and the chamber housing engagement surface 123.2, and in response to the proximal spiral motion of the chamber housing, the inclined surface 121.3 and the engagement surface 123.2 will approach and engage each other and contact. Therefore, any static or viscous friction between the plunger 122 and the chamber housing 123 is overcome by relative rotation. In response to further rotation until the locked position of the shield, the inclined surface will induce a proximal directed force on the piston rod 123, whereby the piston rod 123 and the plunger will be pulled out of the clean room housing.

[0146] When the plunger 136 in the barrel 130 is positioned adjacent to the piston rod 109, the proximal movement of the barrel relative to the barrel holder (which is part of the housing assembly) will induce an overpressure in the barrel. If the reservoir is in fluid contact with the needle cannula, liquid will flow into the clean chamber. An additional feature of pulling the plunger 122 out of the clean chamber housing 121 is provided to overcome the viscous friction between the plunger and the chamber housing 121, but when the fluid connection has been established, pulling will also increase the flow between the reservoir and the chamber housing 121.

[0147] Shell structure

[0148] Figure 3A and Figure 3B A perspective view of features disposed at the inner surface of the tubular housing structure 140, located in an axial cutout of the housing, is shown. Figure 3B In the embodiment, the axial cutout is arranged in a plane containing the central axial line of the window 141, and in Figure 3AIn FIG. 1 , the injection has been rotated 90 degrees about the central axis so that one of the windows 141c is visible behind the cutting plane. FIG. 3C to FIG. 3F As seen in FIG. 1 , the tubular housing structure 140 includes an outer tubular portion 143 and an inner tubular portion 154. In the example shown, the inner tubular portion 154 is integrally connected to the outer tubular portion. The outer tubular portion includes an outer surface having an outer diameter and an inner surface having an inner diameter. Similarly, the inner tubular portion includes an outer surface having an outer diameter and an inner surface having an inner diameter.

[0149] exist Figure 3A and Figure 3B , the inner tubular portion 154 has been removed to obtain a clear view of the structure between the outer tubular portion 143 and the inner tubular portion 154. The figure shows the distal guide structure 142 of the housing protruding from the inner surface. The distal guide structure 142 is suitable for guiding the shield structure 110. The figure also shows the intermediate guide structure 144c of the housing and the proximal guide structure 146c of the housing. Figure 3D Also shown is an intermediate guide structure 144d positioned 180 degrees from 144c with rotational symmetry. The intermediate guide structure 144 also protrudes from the inner surface and provides an integrated connection between the outer tubular portion 143 and the inner tubular portion 154. The intermediate guide structure is also suitable for guiding the connector 170 and the shielding member structure 110. The proximal guide structure 146c forms a recessed portion that sinks into the surface and is suitable for guiding the connector 170. The distal guide 142c, the intermediate guide 144c and the proximal guide 146c all have corresponding guides positioned with rotational symmetry, although not all of them are shown or represented. However, when, for example, the distal guide 142 is mentioned, it can be any distal guide positioned with rotational symmetry, and in the example shown, 142 can refer to any one or both of the distal guides 142c and 142d.

[0150] The distal guide 142 includes a first axial portion 142.1, a first transverse portion 142.2, a second axial portion 142.3, a second transverse portion 142.4, and a third axial portion 142.5, thereby providing a rotation stop. The intermediate guide includes a proximal transverse portion 144.1, a first axial portion 144.2, a distal transverse portion 144.3, and a second axial portion 144.4. The proximal guide includes a first axial portion 146.1, a first transverse portion 146.2, a second axial portion 146.3, a third axial portion 146.4, a ramp portion 146.5, and a flush portion 146.6. The guide surfaces collectively provide a closed track that allows cyclic guidance of the connector. The surface of the transverse portion extends in radial and circumferential directions, the surface of the axial portion extends in axial and radial directions, and the surface of the ramp portion 146.4 extends from the bottom of the recess toward the surface of the flush portion 446.5. The flush portion extends in the axial and circumferential directions and is flush with the inner surface.

[0151] Figure 3C Corresponds to Figure 3A The cross section shown, wherein the inner tubular portion 154 remains therein. It should be noted that the intermediate guide 144 is positioned in the annular space between the outer tubular portion 143 and the inner tubular portion 154. Figure 3D The shell structure 140 is shown in a perspective view, in which a tubular cut has been made. The tubular cut is made in a plane containing the inner surface of the shell structure, and the cut removes the structure outside of this plane. Therefore, only the structure on the inner surface is visible. Figure 3D An internal connection structure 140.3 is shown for connection with a housing insert part 160. The connection structure 140.3 is adapted to position the insert part at an angle relative to the housing structure 140. Figure 3D Also shown is a rib 140.1 which together with the radial surface of the guide 142 supports the radial center position of the shield structure 110. The proximally located rib 140.2 supports the radial position of the return spring 107. A portion of the elongated housing structure 140 is shown adjacent the proximal end of the rib 140.2. Figure 3E Corresponds to Figure 3B The cross section shown, with the inner tubular portion 154 remaining in place, as in 3C. Figure 3F A perspective view as in 3D is shown, but the structures are seen from a different angle, revealing details of the proximal guide 146c. The proximal guide 146c is seen as an edge around the recess, but the edge is positioned in a plane with the inner surface. As can be seen, the guides 142, 144, 146 are arranged with double rotational symmetry. For the proximal guide 146c, the other rotationally displaced guide is not visible due to the angle of the perspective view.

[0152] therefore, FIG. 3A to FIG. 3FThe technical details of the housing structure 140 according to the first embodiment are shown together. The distal guide 142 of the housing is suitable for guiding the shield in rotation and axial direction along the connecting guide surface including the first axial portion 142.1, the first transverse portion 142.2, the second axial portion 142.3 and the second transverse portion 142.4. The intermediate guide is suitable for guiding the connector in rotation and axial direction and includes a proximal transverse portion 144.1, a first axial portion 144.2, a distal transverse portion 144.3 and a second axial portion 144.4. As explained later, the first axial portion 144.2 of the intermediate guide 144 also provides a rotation stop for the shield 110 during injection. The proximal guide is adapted to guide the connector through the working cycle in both axial and rotational directions and comprises: a first axial portion 143.1 providing a rotational stop and adapted to guide proximal axial movement; a first transverse portion 146.2 for guiding counterclockwise rotational movement; a second axial portion 146.2 providing a rotational stop and adapted to guide distal axial movement; and a third axial portion 146.3. The proximal guide also comprises: a ramp portion 146.5; and a flush portion for guiding the connector back to the beginning of the working or dosing cycle.

[0153] Zero point adjustment mechanism

[0154] Figure 4A and Figure 4B A perspective view of a zero adjustment nut 106 according to an alternative embodiment of the present disclosure is shown. As shown, the distal end face is Figure 3A The distal end 106a is visible in FIG. Figure 3B The adjusting nut 106 comprises an internal thread 106.1 for engaging an external thread 109.1 of the piston rod 109 and an external threaded portion 106.2 for engaging an internal thread 154.2 of the housing. In the illustrated embodiment, the external thread 106.2 is shown as two external threaded portions disposed proximally on the nut 106 and protruding from the outer surface. The external thread 106.2 can be made of any number of external threaded portions. Alternatively, the threaded connection 106.2, 154.2 between the nut 106 and the housing can be replaced by a purely rotational guide.

[0155] Furthermore, ratchet arms 106.3 are provided on the outer surface of the adjustment nut 106. In the disclosed embodiment, two ratchet arms 106.3c and 106.3d are positioned at the distal end 106a of the adjustment nut 106 with two-fold rotational symmetry. Any suitable number of ratchet arms 106.3 can be provided. However, in order to improve the rotational stability of the adjustment nut 106, at least two ratchet arms that are rotationally symmetrical are preferred. The two-fold rotational symmetry means that a rotation of 180 degrees around the central axis of the nut 106 does not change the appearance of the nut 106.

[0156] Figure 5 The elongated housing structure 140 cut into half is shown in perspective view, and the inner surface of the structure is visible. The elongated housing structure defines a distal end 140a and a proximal end 140b. As also seen in the figure, an inner tubular portion 154 is provided on the inner surface of the elongated housing structure 140, and the inner tubular portion is suitable for supporting the adjustment nut 106. The inner tubular portion 154 is also shown as a half tube formed due to cutting. The embodiment shown is provided with an axial rack 154.3, which is suitable for engaging with the ratchet arm 106.3 of the nut, which allows the adjustment nut 106 to rotate only in one direction. The allowed rotation direction is clockwise, meaning that the ratchet arm 106.3 and the rack 154.3 interface prevent the nut from rotating counterclockwise relative to the housing. The direction of rotation of the adjustment nut 106 that is prevented or blocked is the same direction as the direction of rotation of the piston rod when advancing in the distal direction during administration. In this way, the adjustment nut cannot be accidentally displaced during administration.

[0157] In some embodiments, the inner tubular portion 154 is further provided with an internal thread 154.2 having a direction such that the adjusting nut 106 is helically screwed in the proximal direction when rotating in the clockwise direction as permitted. Thus, the threaded connection 106.2, 154.2 between the nut and the housing provides an additional gear transmission between the rotation of the adjusting nut 106 and the axial displacement of the rotationally fixed piston rod 109, which can be used, for example, to compensate for a relatively large diametral pitch threaded connection between the adjusting nut 106 and the piston rod 109.

[0158] During assembly of the injection device, it is desirable to ensure that the distance or air gap between the piston rod 109 and the piston 136 within the barrel 135 is minimized. Minimization of the air gap ensures that the drug is expelled from the reservoir in response to moving the piston rod 109 in the distal direction. Figure 6As disclosed in the preferred embodiment shown, the objective is to minimize the air gap between the distal surface of the gasket 104 and the proximal surface of the piston 136 so that when the injection device is arranged in a state allowing storage, the gasket 104 and the piston 136 abut each other and wherein the device is ready for delivery to an end user. In the following, the air gap elimination will be described with reference to the piston rod abutting the piston, but the same considerations apply when the air gap between the piston and the gasket is eliminated.

[0159] When the adjustment nut is rotated relative to the housing structure during final assembly, the piston rod 109 is helically advanced in the distal direction until the piston rod 109 or the washer 104 abuts the piston 136 within the barrel 135. In embodiments comprising a threaded connection 106.2, 154.2 between the nut and the housing, the advancement of the piston rod relative to the housing is compensated or counteracted by the proximal movement of the adjustment nut relative to the housing.

[0160] The rotation of the adjustment nut is preferably accomplished by using a special tool in the production line, which is adapted to engage the adjustment nut and transmit the rotation to the adjustment nut. In a preferred example, the piston rod 109 is arranged to engage with the adjustment nut to provide a subassembly, and the subassembly is then arranged in the inner tubular portion 154 of the housing. In the following, an electronic computerized device is used to detect the relative position of the piston 136 in the barrel 135 to be used for this particular injection device. When the position of the piston 136 and the position of the piston rod 109 are obtained after the injection device is assembled, the computer can determine the required angular displacement of the arranged adjustment nut 106 to position the piston rod to abut against the piston 136.

[0161] During assembly, the position of the proximal end of the piston rod 104 is therefore adjusted by rotating the adjustment nut in the one-way interface with the inner tubular portion 154. What is important here is that the adjustment nut can be rotated in the direction which advances the piston rod 109 into contact with the piston 136.

[0162] After assembly, the piston rod 109 or the washer 104 abuts the piston 136 and it is not possible to further rotate the adjustment nut in the clockwise direction. Furthermore, in any assembled state, there is no external interface between the nut 106 and the external environment. Therefore, it is not possible to bring the external surface into contact with an external tool and apply an external torque to the nut.

[0163] As a result of the above, the adjustment nut 106 is self-locking relative to the housing structure, and it is not necessary to actually fix the nut 106 to the housing. It is therefore not necessary to weld or glue the nut member 11 to the housing.

[0164] Transmission mechanism

[0165] Figure 6Shown is a cross-sectional view of the proximal part of the injection device after zero point adjustment between the piston 136 and the gasket 104. The piston rod 109 is positioned in a proximal position indicating that the first dose has not yet been expelled. Figure 7 A perspective view of the piston rod 109 is shown, with the outer thread 109 . 1 and the axial track 109 . 2 shown in detail. Fig. 8A and Figure 8B The transmission tube 180 is shown in perspective from different angles. The figure shows a tab 183c, which protrudes from the outer surface and provides such a structure for cooperating with the connector 170 during activation of the transmission tube 180 and for relocking the shield structure 110 after the dose has been discharged. The tab 183 includes a distally directed surface 183.1 (distal surface or distally directed surface means that at least one component of the normal vector is oriented in the distal direction) and an axial portion 183.2, which provides a surface oriented in an angular direction for cooperating with the connector 170. The figure also shows a helical structure 184c, which protrudes from the outer surface and is suitable for axially blocking the connector during administration in response to a premature attempt to stop the dose. The tab 183 is located close to the transverse opening provided in the helical structure 184. The figure also shows an axial surface 182c, which is suitable for cooperating with the housing during activation and for providing a rotation stop that defines the end point of the dose. Features 182, 183 and 184 will be explained in detail later in this application.

[0166] The transmission tube 180 is provided with an inward protrusion 180.2, which protrudes from the inner surface and is suitable for engaging the axial track 109.2 of the piston rod 109. The piston rod 109 is adapted to be slidably arranged in the transmission tube, thereby allowing relative axial displacement, but preventing relative rotation. The transmission tube 180 is provided with a ratchet arm 181c, which is used to engage the rack 165.1 in the tubular spring base 165 and thereby form a one-way ratchet interface, so that the transmission tube 180 is rotated only in one direction, which is the counterclockwise direction for dispensing a dose in the disclosed example. Therefore, the ratchet arm 181c prevents the piston rod 109 from rotating in the clockwise direction. In the example shown, the transmission tube includes two ratchet arms 181c, 181d arranged with 2-fold rotational symmetry. The ratchet arm 181 provides a dose click sound in response to the transmission tube 180 and the piston rod 135 rotating in the counterclockwise direction during discharge.

[0167] The engagement between the piston rod 109 and the drive tube 180 prevents relative rotation. Thus, as the adjustment nut 106 is rotated in a clockwise direction during zero adjustment, the nut induces distal translation of the piston rod 109 because the drive tube is locked against rotation in the clockwise direction.

[0168] The torque delivery drive spring 108 shown in Figure 1 is arranged in an embodiment according to the present disclosure within a drive tube 180 and fixedly attached at each end to the drive tube and spring base 165. The distal end includes a distal attachment device 108.1 fixedly attached to the drive tube 180 and a proximal attachment device 108.2 fixedly attached to the spring base 165. The drive spring is wound or tensioned during assembly, thereby storing energy to rotate the drive tube with sufficient torque to deliver the multiple doses without further tensioning.

[0169] Incorporating a torsion spring into the transmission mechanism provides several advantages. The inventors of the present invention have recognized that for embodiments configured with a compression spring, the compression spring advances into the barrel when the energy is released. If the injection device is designed to not allow the compression spring to advance into the barrel, the overall length of the device will increase. Therefore, in a configuration with a limited length, the diameter of the spring is limited by the diameter of the barrel. The inventors of the present invention have found that the torsion spring does not have to extend into the barrel in order to limit the overall length of the device. Therefore, the torsion transmission spring is not limited by the diameter of the barrel or piston rod and is advantageous in a configuration with a limited length.

[0170] The torsion transmission spring according to the embodiment of the present disclosure is arranged at the proximal end of the cylinder and outside the piston rod 109. Therefore, the torsion transmission spring allows the spring to enclose a larger volume, thereby increasing the quality, that is, the amount of spring material (e.g., steel). In other words, since the material or quality used can be increased, the performance related to long-term storage and administration can be improved. As the quality increases, the internal stress of the spring can be reduced, and / or the spring profile can be flatter, thereby minimizing the dosage time variation between the first dose and the last dose of the device. The inventor of the present invention has also found that if the maximum internal stress of the spring is reduced, the stress caused in the plastic part of the support spring is also reduced, which is necessary to allow long-term storage.

[0171] The inventors of the present invention have also found that in embodiments where the torsion transmission spring is arranged inside the transmission tube, the transmission tube can be adapted to provide dose clicks and allow the number of dose clicks to be increased by increasing the diameter. Thus, the number of dose clicks can be increased without extending the axial length of the device.

[0172] According to one embodiment of the present disclosure, the outer surface of the transmission tube includes a dose click providing structure, which is suitable for providing dose clicks, for example, a ratchet arm that engages on teeth provided on a surrounding structure. Alternatively, the ratchet arm is provided on the surrounding structure and the teeth are provided on the transmission tube. As the circumference of the outer surface of the transmission tube 180 increases with the diameter of the transmission tube, the number of dose clicks also increases. In the case of a rotating transmission tube, the number of dose clicks is determined as the relationship between the circumference of the transmission tube and the distance between the dose click providing structure (e.g., the distance between teeth) (number of dose clicks = 2*pi*radius / distance between teeth). Therefore, the number of dose clicks can be increased by increasing the radius without increasing the length of the spring and thereby increasing the length of the device. In contrast, in order to increase the number of dose clicks of a piston driven by a compression spring arranged in the piston, the length of the compression spring must be increased. In the case of a compression spring, the number of dose clicks is determined by the axial extension of the spring divided by the distance between teeth (number of dose clicks = axial extension / distance between teeth).

[0173] In addition, the inventors of the present invention have found that the energy required to release the trigger mechanism (i.e., the activation energy) varies with the internal stress of the transmission spring. Therefore, the activation of the dose engine enabled by the torsion transmission spring requires less force than a similar design based on a compression spring.

[0174] In addition, the inventors have found that embodiments comprising a transmission mechanism based on a torsion transmission spring are easier to assemble than embodiments based on an equivalent compression transmission spring. Compared to compression springs, torsion springs are relatively short and therefore easier to handle.

[0175] The rotating transmission tube is easily adapted to function via an electronic dose capture device that records the rotating structure during drug administration, as described in WO 2019 / 110494, entitled "Drug delivery system with multipolar magnet and sensor system."

[0176] Housing insert part

[0177] Fig. 9A and Fig. 9BTwo different perspective views of a shell insert portion 160 fixedly mounted at the distal end of the elongated shell structure 110 via an alignment structure and a snap structure 160c.3 are shown. The shell insert portion includes a cap mounting track 161. As seen, the cap mounting track 161c includes: an axially extending track portion 161c.2 having a proximal end and a distal end; and a circumferentially extending track portion 161c.3 having a first end and a second end. A snap lock 161c.1 is positioned at the first end of the circumferential track, and the second end is connected to the proximal end of the axially extending track 161c.2, whereby the track portion forms a track for bayonet coupling that cooperates with the inner protrusion of the cap 105. A rotation stop 161c.4 is also provided at the second end of the track 161c. The shell insert portion 160 also includes an axially extending slit 163c on the inner surface, which is used to cooperate with the axially extending rib 116c on the outer surface of the shield (see Fig. 10A ), as will be explained later. The inner housing part 160 also includes a proximal guide 162 for guiding the shield 110. The proximal guide 162d shown extends in the circumferential direction, and in the counterclockwise direction, the guide includes a helical portion 162d.1, a transverse portion 162d.2 with zero pitch, and an axial portion 162d.3. Alternatively, a threaded coupling can be used instead of a bayonet coupling.

[0178] Slim shield structure

[0179] Fig. 10A and Fig. 10B A perspective view of a cylindrical elongated shield structure 110 disposed within a tubular housing 140 is shown. Fig. 10A The distal end face of the shield structure 110 can be seen on Fig. 10B The proximal surface can be seen above. Fig. 10C A portion of the shield structure is shown in a perspective side view. The elongated shield structure 110 includes a tubular portion including an outer surface having an outer diameter and an inner surface having an inner diameter. An axially extending rib 116c is disposed at the distal end and protrudes from the outer surface. The rib is adapted to cooperate with an internal rib of the cap 105 and is adapted to cooperate with a slit 163 on the inner surface of the housing insert portion 165.

[0180] The shield structure 110 also includes a stepped spiral guide 112, which is arranged on the outer surface and is suitable for cooperating with the proximal guide 162 of the shell insert part and the distal guide 142 of the shell. The stepped spiral guide 112 is arranged in the annular space between the outer surface of the tubular part of the shield structure 110 and the inner surface of the outer tubular part 143 of the shell. The stepped spiral guide includes a continuous protrusion structure extending in the axial and circumferential directions, and includes a proximal lateral protrusion part, a proximal left-handed spiral protrusion part, an intermediate lateral protrusion part, a distal left-handed spiral protrusion part, and a distal lateral protrusion part. The continuous protrusion structure includes a plurality of axially and circumferentially oriented surface parts, which provide a guide surface (a circumferential surface or a circumferentially oriented surface means that at least one component of the normal vector is oriented in the circumferential direction). The surface parts can be seen in Figure 10 and are referred to by the following terms and figure marks. The proximal axial guide portion 112.1, the first proximal lateral guide portion 112.2, the second proximal lateral guide portion 112.3, the first proximal helical guide portion 112.4, the second proximal helical guide portion 112.5, the first intermediate lateral guide portion 112.6, the second intermediate lateral guide portion 112.7, the first distal helical guide portion 112.8, the second distal helical guide portion 112.9, the first distal lateral guide portion 112.10, the second distal lateral guide portion 112.11 and the distal axial guide portion 112.12. In this way, the guide portions 112.2, 112.4, 112.6, 112.8 and 112.10 provide the distal face of the stepped helical guide 112, and the guide portions 112.3, 112.5, 112.7, 112.9 and 112.11 provide the proximal face.

[0181] The elongated shield structure 110 also includes a proximal guide 114 positioned at the proximal end of the shield structure 110. Fig. 10A The distal end can be seen on Fig. 10B The proximal face can be seen on the proximal guide 114. The proximal guide 114 is adapted to cooperate with the connector 170 and the intermediate guide 144 of the housing. The proximal guide 114 extends in the axial and circumferential directions and comprises a first left-handed helical portion 114.1, a first right-handed helical portion 114.2, a second right-handed helical portion 114.3, a second left-handed helical portion 114.4, a first axial portion 114.5, a first transverse portion 114.6, a second axial portion 114.7, a third axial portion 114.8 and a second transverse portion 114.9.

[0182] The guide portions 114.1 to 114.9 are all surface portions, and the guide portions 114.1, 114.2, 114.3, 114.4 and 114.9 provide the proximal face of the proximal guide 114, and the surface portion 114.6 provides the distal face, i.e., observable from the proximal position and the distal position, respectively. The guide portions 114.1, 114.2, 114.3 and 114.4 of the proximal face are adapted to cooperate with the connector during an activation operation.

[0183] The guide portion 114.6 of the distal face of the proximal guide is adapted to cooperate with the connector in response to a premature release of pressure on the shield during drug administration, as will be explained in detail later in this application.

[0184] The third axial portion 114.8 is adapted to cooperate with the intermediate guide 144 of the housing and provide a rotation stop, thereby preventing the shield from further counterclockwise rotation relative to the housing during administration. Similarly, the second transverse portion 114.9 provides an axial stop that cooperates with the intermediate guide 144 and prevents further proximal movement of the shield during administration.

[0185] The proximal guide 114 comprises a locking structure 115 comprising guide portions 114.4 and 114.5, which in the illustrated embodiment is a part of a hook-like structure. As will be explained in detail later, the locking structure 115 is adapted to be releasably locked to a corresponding hook-like structure of the connector 170 during administration.

[0186] The shield also comprises a click arm 113 having an axial surface portion 113 . 1 providing a rotation stop. In an initial state, the click arm is radially compressed by the inner surface of the housing insert portion 160 .

[0187] Connectors

[0188] Fig.11A and Fig. 11B A perspective view of a connector 170 disposed within the tubular housing 140 and between the elongated shield structure 110 and the transmission tube is shown. The connector 170 is adapted to establish a connection between the shield and the transmission tube and to activate the transmission tube 180. The connector 170 is also operatively connected in an automatic relocking mechanism adapted to automatically relock the shield at the end of a dose. The connector 170 comprises a distal guide 172 adapted to cooperate with the proximal guide 114 of the shield. The distal guide 172 extends in a circumferential and axial direction and comprises a left-handed helical portion 172.1, a right-handed helical portion 172.2, a first axial portion 172.3, a transverse portion 172.4, and a second axial portion 172.5.

[0189] The guide portions 172.1 to 114.5 are all surface portions, and the guide portions 114.1 and 114.2 provide the distal face of the distal guide 172, and the surface portion 172.4 provides the proximal face. The guide portions 172.1 and 172.2 of the distal face are adapted to cooperate with the proximal guide of the shield during an activation operation. The guide portion 172.4 of the proximal face is adapted to cooperate with the guide portion 114.6 of the proximal guide of the shield in response to a premature release of pressure on the shield during administration, which will be explained in detail later in this application.

[0190] The return spring 107 pushes the connector in the distal direction. Therefore, the left-handed helical portion pushes the connector in the counterclockwise direction and pushes the shield in the counterclockwise direction in response to establishing engagement between the left-handed helical portion 172.1 and the first left-handed helical portion 114.1 of the proximal guide of the shield, or in response to establishing engagement between the left-handed helical portion 172.1 and the second left-handed helical portion 114.1 of the proximal guide of the shield.

[0191] The distal guide 172 includes a locking structure 171, which includes a left-handed helical portion 172.1 and a first axial portion 172.3. The locking structure 171 is part of a hook-like structure that is adapted to releasably lock to a corresponding hook-like structure of the proximal guide 114 of the shield. In response to abutting the second left-handed helical portion 114.4 of the locking structure 115 of the shield with the left-handed helical portion 172.1 of the locking structure 171 of the connector under axial compression from the return spring 107, a releasable lock is established between the hook-like structures. Therefore, the shield is pushed in the counterclockwise direction, and the connector is pushed towards the counterclockwise direction, and an abutment is established between the first axial portion 172.3 of the connector and the first axial portion 114.5 of the shield. In order to release the lock, in response to the counterclockwise rotation of the connector, the friction established in the abutment between the two left-handed helical portions 114.4 and 172.1 must be overcome.

[0192] The connector 170 comprises: a tubular portion 170.1 having a full 360 degree circumference; and two axially extending tube portions 170.2, which are formed by two cutouts in the tube and thus provide only a portion of the circumference. The connector 170 has an outer surface with an outer diameter and an inner surface with an inner diameter. Fig. 12A and Fig. 12B1, which are cross-sectional views of the proximal end of the injection device, the outer surface of the connector is arranged in close proximity to the inner surface of the outer tubular portion 143 of the housing. The connector surrounds the inner tubular portion 154 of the housing and the transmission tube 180. The inner diameter of the connector is larger than the outer diameter of the tubular portion of the shield structure 110, and therefore, the guide portions 172.1 to 172.4 are provided with shoulders protruding in the negative radial direction for achieving contact between the proximal guide 114 of the shield and the distal guide 172 of the connector.

[0193] The connector also includes an intermediate guide 174 adapted to cooperate with the intermediate guide 144 of the housing and thereby control the position of the connector relative to the housing. The intermediate guide of the connector extends in the axial and circumferential directions and includes: a first axial portion 174.1 providing a rotation stop; a first transverse portion 174.2; a second axial portion 174.3; a left-handed helical portion 174.4; a third axial portion 174.5; a fourth axial portion 174.6; and a second transverse portion 174.7.

[0194] The intermediate guide 174 of the connector defines a blocking structure comprising a second transverse portion 174 . 7 adapted to prevent accidental axial movement of the connector and thereby accidental activation of the transmission tube 180 .

[0195] The intermediate guide 174 further defines a seat or locking structure 173 comprising a first lateral portion 174.2 and a second axial portion 174.3, wherein the locking structure is adapted to provide a rotational lock to prevent rotation and distal movement of the connector in the initial position. In the initial position, the connector 170 is in its most distal position.

[0196] The connector 170 further comprises an activation tab 178 disposed on the inner surface and extending radially therefrom in a negative radial direction. The activation tab 178 comprises a first transverse portion 178.1 providing a proximal contact surface adapted to activate the transmission tube 180. The activation tab further comprises an axial portion 178.2 adapted to release the automatic relocking mechanism in response to a clockwise impact from the transmission tube 180, and a second transverse portion 178.3 providing a retaining portion that prevents a split dose in response to a premature release of pressure on the shield.

[0197] The connector further comprises a proximal guide in the form of a click arm 176 adapted to cooperate with the proximal guide 146 of the housing. The diameter defined by the circle surrounding the two-fold symmetrically arranged click arms 176c and 176d in their relaxed state is greater than the outer diameter of the connector and greater than the inner diameter of the housing. Thus, in response to arranging the connector 170 within the outer tubular portion 143 of the housing, wherein the click arm 176 contacts the inner surface, the click arm is deflected in a negative radial direction. In this position, the click arm 176 exerts a radial force in a radial direction on the inner surface of the housing. The click arm comprises: a first axial portion 176.1 for cooperating with the axial guide portions 146.1 and 146.3 of the proximal guide of the housing; and an outer surface portion 176.2 extending in the axial and circumferential directions, adapted to cooperate with the axial portion 146.4, the ramp portion 146.5 and the flush portion 146.6.

[0198] Proximal portion of the injection device

[0199] return Fig. 12A and Fig. 12B . Fig. 12A and Fig. 12B A cross section of the proximal end of the device is shown. Fig. 12A A central cross section is shown including windows 141 (although they are located on the distal portion of the device and are not visible in Figure 12). Fig. 12B Shows relative to Fig. 12A The central cross section is rotated 90 degrees. The transmission tube 180 includes four tubular sections, such as Fig. 12B The first tubular portion 185 , the second tubular portion 186 , the third tubular portion 187 and the fourth tubular portion 188 are shown.

[0200] The first tubular portion 185 is also a distal tubular portion and is arranged within the inner tubular portion 154 of the housing. The distal tubular portion includes an outer tubular portion 185.1 in contact with the inner tubular portion 154. The outer tubular portion 185.1 is connected to the second tubular portion 186 and also includes an axial surface portion 182c, which is suitable for cooperating with the housing during activation and for defining the end point of the dose. The outer tubular portion 185.1 also includes a distal helical surface portion 189c, which is suitable for cooperating with the proximal helical surface portion of the inner tubular portion 154 of the housing during administration (see also Fig. 8A). The distal tubular portion 185 further comprises an intermediate tubular portion 185.2 extending in the proximal direction. The proximal portion of the intermediate tubular portion 185.2 is surrounded by the second tubular portion 186 and thereby defines an annular spring receiving space, thereby providing a distal base for the transmission spring 108. The outer surface of the proximal portion of the intermediate tubular portion 185.2 defines a spring catch 180.2, which is used to axially snap onto the transmission spring 108 in response to the axial insertion of the transmission spring into the annular spring receiving space. The distal tubular portion 185 further comprises an inner tubular portion 185.3 extending distally from the intermediate tubular portion and comprising an inward protrusion 180.2 adapted to engage the axial track 109.2 of the piston rod 109.

[0201] The second tubular portion 186 comprises raised helical structures 184c and 184d on the outer surface. The second tubular portion 186 further comprises an axial surface portion 182d, which is arranged in two-fold rotational symmetry with the axial surface portion 182c, adapted to cooperate with the housing during activation and to define the end point of the dose. The second tubular portion 186 further comprises a distal helical surface portion 189d, which is arranged in two-fold rotational symmetry with the distal helical surface portion 189c, adapted to cooperate with the proximal helical surface portion 157d of the inner tubular portion 154 of the housing during administration (see also Fig. 8A and Fig.13A ). The protruding helical structure 184 protrudes from the outer surface of the second tubular portion 186 and extends to the inner surface of the connector 170. The helical structure 184 is suitable for axially blocking the connector during administration in response to premature release of pressure on the connector, whereby the helical structure 184 will block the axial movement of the activation tab 178 protruding inwardly from the inner surface of the connector 170.

[0202] The second tubular portion 186 and the third tubular portion 187 are surrounded by the return spring 107. The second tubular portion 186 and the third tubular portion 187 together with the inner tubular portion 165.2 of the spring base 165 define an annular space that accommodates a portion of the transmission spring 108. The fourth tubular portion 188 of the transmission tube 180 is also a proximal tubular portion and includes a ratchet arm 181c for engaging the rack 165.1 within the outer tubular portion 165.3 of the spring base.

[0203] Activation mechanism

[0204] Fig.13A A perspective view of the inner tubular portion 154 of the housing and the transmission tube 180 is shown, wherein the distal tubular portion 185 has been inserted into the inner tubular portion 154 and is therefore not visible in this figure, where the transmission tube 180 is in the home position. Before the first dose, the home position is also referred to as the starting position. After the first dose, the home position is also referred to as the end of the dose position. Fig. 13BA cross section along the indicated line CC and viewed from the proximal end is shown. Fig. 13C A cross section CC viewed from the distal end is shown.

[0205] Fig.13A Also shown is an activation tab 178 on the inner surface of the connector 170 (only the tab and not the rest of the connector is shown). Fig.13A ). The connector with the activation tab 178 is arranged in a position where it contacts the protruding tab 183, thereby preparing to transmit the proximal movement to the transmission tube, whereby the transmission tube can be activated. The transmission tube 180 is biased in the distal and counterclockwise direction by the transmission spring. Fig.13A , the transmission tube is shown in a rest position, wherein the axial surface portion 182 abuts the axial surface portion 156 of the inner tubular portion 154 of the housing, thereby preventing counterclockwise rotation of the transmission tube 180. In the rest position, the distal helical surface portion 182 also abuts the proximal helical surface portion 157 of the inner tubular portion 154 of the housing, thereby preventing distal movement of the transmission tube 180.

[0206] Fig.13D Shown in detail: the proximal end of the spiral surface portion 157d.1, which defines the starting point of the spiral dosing track; and the distal end of the spiral surface portion 157d.2, which defines the end point of the spiral dosing track. Similarly, the distal spiral surface portion 189d defines a front point or edge 189d.1 and a rear point or edge 189d.2. In response to moving the connector in the proximal direction, the activation tab 178 causes the proximal movement of the transmission tube 180 when it is arranged to abut against the protruding tab 183. Therefore, the front edge 189d.1 moves proximally along the axial surface portion 182d until it passes through the proximal end of the axial surface portion and reaches the starting point 157d.1 of the spiral dosing track. Due to the counterclockwise bias of the transmission tube 189, the transmission tube 189 rotates in the counterclockwise direction, and due to the distal bias, the front edge 189d.1 is forced to contact the spiral dose track of the inner tubular portion 154. In the following, the transmission tube with the leading edge 189d.1 travels along the spiral dose track with a distal spiral movement until it reaches the end point 157d.2. A small depression is noted at the end point 157d.2 of the spiral dose track. However, since this depression is smaller than the extension of the spiral surface portion 189d, it does not affect the spiral movement of the leading edge 189d.1. The same effect is obtained by the angular displacement surface portion 182c and the distal spiral surface portion 189c.

[0207] Cross section of the injection unit in its initial state

[0208] Fig.14A and Fig. 14B A cross section of an injection device 100 is shown. Fig.14A Corresponds to Fig. 12AA central cross section including the window 141 is shown. Fig. 14B Shows that relative to Fig.14A The central cross section of the device after the view is rotated 90 degrees. The transmission tube 180 includes 4 tubular parts, such as Fig. 12B shown.

[0209] FIG. 14 shows the device 100 in an initial state, wherein the shield has been rotated to activate the device. The shield has been moved proximally with the needle assembly 120 in a spiral motion. The proximal movement of the shield has caused the proximal movement of the needle hub 125, whereby the needle 124 has established a fluid connection with the reservoir in the barrel 135. The barrel 135 and the plunger 136 have also moved in the proximal direction, and due to the abutment with the gasket 104, the plunger has stopped proximal movement, whereby the chamber of the cleaning assembly 120 has been filled (the gasket 104 is in the Figure 6 14).

[0210] Device Operation

[0211] FIG. 15 is used to describe the working principle of an embodiment of the present disclosure from a user's perspective, and a more detailed description of the working principle will be described later with reference to FIG. 16 . Fig.15A A user operation of the injection device 100 for administering a first dose is shown, and Fig. 15B An operation for taking a subsequent dose is shown, wherein the subsequent dose may be any fixed dose in a sequence between a first dose and a last dose of a plurality of fixed doses. The injection device can be stored and delivered in a secondary packaging, and in the unpacked state (A1), the injection device has been unpacked from the secondary packaging.

[0212] like Fig.15AAs shown, when the user wishes to take the first fixed dose, the injection device is unpacked and thus is placed in an unpacked state (A1). Thereafter, the injection device is activated by the user. Activation can be accomplished by grasping the main part 102 of the device with the right hand and grasping the cap 105 with the left hand. Thereafter, the user rotates the cap in a counterclockwise direction (for the example shown). As a result, the cap disengages the snap from the cap snap 161.1 of the housing assembly and engages the needle shield, whereby the needle shield follows the rotation of the cap 105 until the cap 105 has turned to the rotation stop 161.4. Due to the stepped spiral guide 112 of the shield and the proximal guide 162 of the housing assembly, the needle shield undergoes a combined proximal and rotational movement in response to the user turning the cap. In addition, by this initial rotation of the cap and the combined rotational and proximal movement of the needle shield, the needle cannula 124 pierces the septum of the barrel 135, thereby establishing fluid communication with the drug reservoir in the barrel 135. Furthermore, in this operation, the barrel 135 is displaced proximally and pushed against the piston rod 109 or the piston gasket 104. Since the cannula has established a fluid connection and since the piston is arranged in abutment with the piston rod, the integrated needle is pre-primed, as will be explained in detail later. When the cap reaches the rotation stop, the injection device is positioned in the cap unlocked and initial state (B1), in which the cap is unlocked and positioned to be removed. The initial state is also shown in the cross section of FIG. 15 .

[0213] In a next step, the user pulls the cap 105, whereby the injection device is arranged in the cap-uncapped state (C1) and wherein the shield is locked against axial translation.

[0214] Thereafter, the user manually rotates the shield in a counterclockwise direction, whereby the device is arranged in a shield unlocked state (D1), the shield being arranged in an unlocked position and being able to be pressed proximally into the housing. Due to the guide between the shield 112 and the housing 162, the shield is subjected to combined proximal and rotational movement when operating between the cap disengaged state and the shield unlocked state. During the rotational unlocking movement of the needle shield, the needle shield exposes the barrel inspection window 141 in the housing, whereby the drug in the barrel can be inspected. In addition, the piston 136 is also visible in the inspection window 141, and the position of the piston 136 relative to the fixed dose scale on the housing indicates the progress of the piston during use, thereby indicating the remaining number of fixed doses in the reservoir. Fig.15A In the shield unlocked state (D1), the piston 136 is arranged in the initial position and 4 doses remain in the reservoir. During the proximal movement of the needle shield, the distal protrusion of the needle tip passes through the septum at the distal end of the cleaning assembly 120, thereby releasing any excess pressure in the needle.

[0215] After this, the user presses the needle shield against the injection site, whereby the shield and connector 170 are displaced proximally against the force of the shield return spring 107. Therefore, the needle is inserted into the skin or subcutaneous layer of the patient. By this operation, the axial movement of the shield triggers the transmission mechanism, and a fixed dose is delivered by the needle cannula in the dosing state (E1). At the end of the dose, the piston 136 has moved to the next position, which is indicated by the fixed dose remaining scale on the housing, and the injection device can be removed from the injection site. The cutout window of the remaining scale shows that the piston is in the next position. As the piston 136 advances in the dosing state, it may be useful to define sub-states for the corresponding dose states: the initial dosing state (E2.1) and the final dosing state (E2.2), in which the piston is in a pressurized proximal position and a relaxed distal position, respectively.

[0216] After the dose is completed, the user removes the device from the skin, thereby releasing the pressure from the shield. The shield is thus moved in the distal direction due to the action of the return spring 107. Due to the guides 112, 162 between the shield and the housing and the guides 114, 142 between the shield and the connector 170, the shield is subjected to a distal movement and subsequently a combined distal and rotational movement, whereby the shield automatically returns to the re-locked state (F1).

[0217] Thereafter, the user moves the cover cap 105 axially to put the device in the capped state (G1), which is Fig.15A The last state shown in the sequence shown. Within the same sequence, the cap unlocked state and the cap closed state technically differ in that in the cap closed state the cartridge contains less dose.

[0218] Finally, the cap is rotated so that the snap locks to the housing assembly to enter the cap locking state (A2), as shown in FIG. Fig. 15B shown.

[0219] The cap locked state (A2) differs from the box open state (A1) in that the device has been activated. Fig.15A and Fig. 15BThe shield shown in state (A2) is proximal and rotationally displaced compared to the position of the shield in state (A1). In addition, in state (A2), the dose contained in the barrel is less than that in state (A1). When the user turns the cap to take a subsequent dose, the cap is rotated to the cap unlocking position without rotating the shield because the shield has been rotated to the starting but axially locked position. The cap unlocking state (B2) is different from the cap unlocking state (B1) in that the dose contained in the barrel in state (B2) is less than that in state (B1), and corresponding differences between C1-C2, D1-D2 ... G1-G2, A2-A3, B2-B3 ... etc. can be observed. This operation mode can continue until the final dose has been delivered, wherein it will be impossible to trigger the transmission mechanism again.

[0220] Detailed description of the device operation

[0221] 16A to 16T Collectively, the relative and functional arrangements of the various structures during a sequence of states of the injection device 100 are shown, thereby illustrating the operation of the device in detail.

[0222] In one embodiment of the present disclosure, an injection device 100 for sequentially delivering multiple fixed doses comprises: a housing including an elongated housing structure 140, a barrel holder 130 and a housing insert portion 160; an internal thread; a shield including an elongated shield structure 110 and a needle tip 119; a needle hub 125 including a fixedly attached needle cannula 104; a cap 105 removably mounted on the housing and adapted to cover the distal end of the shield; a barrel 135 having a movably arranged barrel plunger 136; and a transmission mechanism comprising a torsion transmission spring 108, a transmission tube 180 and a piston rod 109 having an external thread for cooperating with the internal thread of the housing, the piston rod being arranged to be connected to the plunger 136, and wherein the torsion spring is adapted to provide a torque for rotating the transmission tube 180 relative to the housing. The transmission tube comprises a ratchet mechanism that ensures rotation in a dosing direction and blocking in a non-dosing direction. The transmission tube is axially splined with the piston rod, thereby allowing relative axial movement and preventing relative rotation. The transmission tube is suitable for advancing the piston rod in response to rotating the transmission tube in the dosing direction, and due to the threaded connection with the housing, the piston rod is suitable for advancing the plunger 136 in the cylinder 135 to discharge a fixed dose. The transmission mechanism is suitable for activating by changing the transmission tube from the distal position (wherein the transmission mechanism is in a fixed mode) to the proximal position (wherein the transmission mechanism is in a dosing mode). At the distal position, the transmission tube is rotationally locked to the housing. At the proximal position, the transmission tube is rotationally unlocked with the housing, and the torque provided can rotate the transmission tube to a predetermined angle to discharge a fixed dose. In the fixed mode of the transmission mechanism, the piston rod rotates and axially locks, and the piston rod is rotationally locked to the housing by being connected to the spline of the transmission tube 180, and is axially locked by being threadedly connected to the housing.

[0223] The torsion spring is pre-tensioned to deliver multiple doses without binding during use.The transmission mechanism is adapted to change modes immediately after activation and, as explained later, the transmission mechanism is adapted to be repeatedly activated until the last dose has been expelled.

[0224] The cap can be arranged in an axially locked position and an axially unlocked position. The cap can be changed between the positions by rotating the cap relative to the housing. With the cap in the axially unlocked position, the cap can be removed from the housing.

[0225] The needle hub 125 is movably arranged on the housing and can move between a distal position and a proximal position relative to the housing. The needle hub 125 is arranged to be connected to the barrel and is rotationally locked relative to the housing. For the needle hub in the distal position, the proximal end of the needle cannula is arranged at the distal end of the barrel that can pierce the septum. For the needle hub 125 in the proximal position, the needle cannula extends through the septum and is positioned to communicate with the reservoir fluid of the barrel. In response to moving the needle hub from the distal position to the proximal position, the needle cannula pierces the septum of the barrel and moves the barrel a certain proximal distance relative to the housing and the axially locked piston rod.

[0226] The shield can be arranged in different positions. The initial position is defined by an initial angular position and a corresponding initial axial position. The locked position is defined by a locked angular position and a corresponding locked axial position. The unlocked distal position is defined by an unlocked angular position and a corresponding distal unlocked axial position. The unlocked proximal position is defined by an unlocked angular position and a corresponding proximal unlocked axial position. In the initial position, the shield is adapted to prevent axial and clockwise movement, and to allow counterclockwise movement. In the locked position, the shield is adapted to prevent clockwise and axial movement. In this position, the shield is also adapted to allow counterclockwise rotation. In the unlocked distal position, the shield is adapted to prevent counterclockwise and distal movement of the shield, and is also adapted to allow proximal movement. In the unlocked distal position, the shield is also adapted to allow clockwise rotation when the applied torque exceeds a predetermined threshold. For the shield in the initial position and the locked position, the needle tip is covered by the shield. In the unlocked position, the shield is adapted to move from an unlocked distal position (wherein the needle tip is covered by the shield and where pressure in the reservoir can be released) and toward an unlocked proximal position (wherein the needle tip extends further away from the shield and can be inserted into the subcutaneous layer of the subject). The shield is manually operable by a user between different positions. As presented for the shield in the initial position, the locked position, the distal unlocked position, and the proximal unlocked position define four different sets of angular and axial positions: three different angular positions and four different axial positions.

[0227] The connector can be arranged in an initial position defined by an initial angle and an initial axial position, wherein it is positioned to be rotationally locked to an intermediate guide 144 of the housing, wherein the intermediate guide 144 also prevents distal movement of the connector. The connector is biased in the distal direction by a return spring 107.

[0228] 16A to 16T Collectively, the injection device 100 is shown in different states and intermediate arrangements, wherein exterior portions of the housing and the cap have been cut away to show some of the internal structure.

[0229] Fig.16AThe injection device is shown in an unpacked state and shows the cap 105, the shield structure 110, the housing insert 160, the cartridge holder 130, the connector 170, the transmission tube 180 and the return spring 107 and the spring base 165. Fig.16A In the figure, reference numerals are also provided for the proximal guide 162 of the housing insert part, the stepped spiral guide 112 of the shield and the distal guide 142 of the housing. The user receives the device from the pharmacy and unpacks the device from the secondary packaging. By unpacking, the user has set the injection device in an unpacked state.

[0230] FIG. 16B to FIG. 16E Together they show Fig.16A The unpacking status shown is the same as Fig.16F An intermediate arrangement between the cap unlocked states shown. Fig. 16B , reference numerals are shown for details of the proximal guide 162 and the distal guide 142. These details are: helical portion 162.1, transverse portion 162.2, axial portion 162.3, first axial portion 142.1, first transverse portion 142.2, second axial portion 142.3 and second transverse portion 142.4. Fig. 16C and Fig.16E The details of the stepped helical guide 112 are shown in the figure. These details are: a proximal axial guide portion 112.1, a first proximal lateral guide portion 112.2, a second proximal lateral guide portion 112.3, a first proximal helical guide portion 112.4, a second proximal helical guide portion 112.5, a first intermediate lateral guide portion 112.6, a second intermediate lateral guide portion 112.7, a first distal helical guide portion 112.8, a second distal helical guide portion 112.9, a first distal lateral guide portion 112.10, a second distal lateral guide portion 112.11 and a distal axial guide portion 112.12. The details of the proximal guide 114 of the shield are shown in the figure. Fig.16D C. These details are: first left-handed helical portion 114.1, first right-handed helical portion 114.2, second right-handed helical portion 114.3. The reference numerals for the details of the distal guide 172 of the connector are in Fig. 16C These details are: left-handed helical portion 172.1, right-handed helical portion 172.2, first axial portion 172.3.

[0231] Unpacking status

[0232] The first user operation is to turn the cap counterclockwise until it reaches the cap axial unlocked position, whereby the shield changes from the initial position to the locked position, and whereby the device changes from the unpacking state to the cap unlocked state, also called the shield initial state, through multiple intermediate arrangements.

[0233] In more detail, Fig.16A The arrangement of the injection device is shown arranged in an unpacked state. The cap 105 is arranged in an axially locked position and the shield is arranged in an initial position. A small circumferential gap is provided between the axially extending ribs 116 protruding from the inner surface of the cap and the axially extending ribs 105.1 protruding from the outer surface of the shield. The protrusions on the inner surface of the cap 105.2 are releasably retained in the cap mounting track 161 by snap locks 161.1.

[0234] Fig. 16B A first intermediate arrangement of the injection device is shown. The circumferential gap has been eliminated by rotation and an abutment has been provided between the axially extending rib 116 of the cap and the axially extending rib 105.1 of the shield. By further rotation, the torque will be transmitted from the cap to the shield. In the first intermediate arrangement, a circumferential gap is provided between the first proximal helical guide 112.4 of the shield and the helical portion 162.1 of the insert part of the housing, thereby allowing relative counterclockwise rotation between the shield and the housing. In addition, only a very small axial gap is provided between the first proximal transverse guide portion 112.2 of the shield and the transverse portion 162.2 of the housing, thereby preventing the distal end of the shield from moving beyond the axial gap. Similarly, only a very small axial gap is provided between the second proximal transverse guide portion 112.3 of the shield and the first transverse portion 142.2 of the housing, thereby preventing the proximal end from moving beyond the axial gap.

[0235] exist Fig. 16C In the second intermediate arrangement of the injection device shown, the circumferential gap between the stepped helical guide 112 and the proximal guide 162 of the housing has been eliminated to provide abutment between the first proximal helical guide 112.4 of the shield and the helical portion 162.1 of the housing. In this position, a circumferential gap is also provided between the second proximal transverse guide portion 112.3 of the shield and the first transverse portion 142.2 of the housing, whereby the transverse portion 142.2 does not prevent axial movement.

[0236] exist Fig.16DIn the third intermediate arrangement of the injection device shown, the shield has been further rotated. In response to the rotation, the abutment between the helical guide portion of the shield and the housing provides a combined rotational and proximal movement relative to the housing. As a result, the stepped helical guide 112 has moved proximally along the helical guide portion 162.1. The stepped helical guide portion includes a front edge and a rear edge defined according to the direction of relative movement between the shield and the housing. Due to the relative movement, the area of ​​abutment gradually becomes smaller until the rear edge of the first proximal helical guide portion 112.4 reaches the proximal edge of the helical portion 162.1. At this position of minimum abutment, in response to further counterclockwise rotation, the abutment between the stepped helical guide and the housing shifts from abutment between the helical portions to abutment between the lateral portions, thereby guiding the shield in pure rotation. Fig.16D In the embodiment, the abutment between the first proximal helical guide portion 112.4 of the shield and the helical portion 162.1 of the housing is arranged between the distal portion (close to the rear edge) and the rear edge of the first proximal helical guide portion 112.4. Fig.16D As shown, the connector is arranged in an initial angular position and axial position, in which it is rotationally locked to the housing and is prevented from distal movement, the connector being biased in the distal direction by the return spring 107. Due to the proximal helical movement of the shield, abutment in the rest position has been established between the first left-handed helical portion 114.1 of the proximal guide of the shield and the left-handed helical portion 172.1 of the connector. In this position of the shield, a small axial gap is provided between the second proximal helical guide portion 112.5 and the first transverse portion 142.2, thereby preventing a purely axial movement in the proximal direction exceeding the gap.

[0237] exist Fig.16E In the fourth intermediate arrangement of the injection device shown, the shield has been further rotated. The abutment between the lateral portions of the stepped spiral guide 112 and the housing provides a pure rotation. Therefore, the stepped spiral guide 112 has moved in a counterclockwise direction along the lateral portion 162.2. The lateral guide portion 162.1 defines a first edge and a second edge, wherein the second edge is positioned counterclockwise to the first edge. The first intermediate lateral portion 112.6 includes a front edge and a rear edge defined according to the direction of relative movement between the shield and the housing. Due to the relative movement, the area of ​​abutment gradually becomes smaller until the rear edge of the first intermediate lateral guide portion 112.6 reaches the second edge of the lateral portion 162.2. At this position of minimum abutment, in response to further counterclockwise rotation, the abutment between the stepped spiral guide and the housing shifts from abutment between the lateral portions to abutment between the spiral portions, whereby the shield is guided to perform a spiral movement. Fig.16EIn the embodiment, the abutment between the first intermediate lateral guide portion 112.6 of the shield and the lateral portion 162.2 of the housing is arranged between the middle and rear edges of the guide portion. In the illustrated arrangement, a small axial gap is arranged between the second intermediate lateral guide portion 112.7 and the first lateral portion 142.2 of the housing, thereby limiting proximal movement.

[0238] Cap unlocked, shield activated and locked states

[0239] When the cover is unlocked and the shield is locked, Fig.16F As shown, the cap 105 is arranged in an axial unlocked position and the shield is arranged in a locked position. The cap is positioned by a protrusion 105.2 on the inner surface of the cap at the second end of the circumferential track portion 161.3, whereby the protrusion 105.1 is aligned at an angle with the axial track portion 161.2 and can move in the distal direction. The shield is arranged in a locked position, wherein abutments are established between the stepped spiral guide 112 and both the transverse portion 162.2 and the spiral portion 162.1. In addition to the abutments between the first left-handed spiral portion 114.1 of the proximal guide of the shield and the first left-handed spiral portion 172.1 of the connector, additional abutments are also provided between the first right-handed spiral portion 114.2 and the right-handed spiral portion 172.2. Due to the proximal movement of the shield, the connector has moved proximally relative to the initial axial position and against the biasing force of the spring 107. The connector is still rotationally locked. To prevent clockwise rotation towards the unpacked state, the axial surface portion 113.1 of the click arm abuts the axial portion 162.3 of the housing. The click member 113 has been deflected in the radial direction from the compressed state behind the insert portion 162 of the housing.

[0240] Cap off state

[0241] The second user operation is to pull the cap out in the distal direction, whereby the device changes from the cap-unlocked state to the cap-disengaged state.

[0242] When the cap is removed, Figure 16G As shown, the cap has been removed from the main part 102 of the injection device, as shown in FIG. Fig.16F The shield is positioned relative to Fig.16F The arrangement in is unchanged and remains in the locked position. The shield is axially locked but is allowed to perform a proximal helical movement guided by the abutment between the stepped helical guide 112 and the helical portion 162.1 of the housing.

[0243] Shield unlocked state

[0244] The third user operation is to rotate the shield in the locked position in the counterclockwise direction until it reaches the unlocked position and the device has thereby been changed from the cap disengaged state to the shield unlocked state through a number of intermediate arrangements.

[0245] Fig.16H A first intermediate arrangement is shown in which the shield has been rotated. In response to the rotation, the abutment between the helical guide portion of the shield and the shell provides a combined rotational and proximal movement relative to the shell. Accordingly, the stepped helical guide 112 has moved proximally along the helical guide portion 162.1. The stepped helical guide portion includes a leading edge and a trailing edge defined according to the direction of relative movement between the shield and the shell. Due to the relative movement, the area of ​​abutment gradually becomes smaller until the trailing edge of the first distal helical guide portion 112.8 reaches the proximal edge of the helical portion 162.1. At this position of minimum abutment, in response to further counterclockwise rotation, the abutment between the stepped helical guide and the shell shifts from abutment between the helical portions to abutment between the lateral portions, thereby guiding the shield in pure rotation. Fig.16H In the embodiment, the abutment between the first distal spiral guide portion 112.8 of the shield and the spiral portion 162.1 of the housing is arranged between the proximal portion (close to the front edge) and the rear edge of the first distal spiral guide portion 112.8. Fig.16H In the position of the shield shown, an abutment has been established between the first left-handed helical portion 114.1 of the proximal guide of the shield and the first left-handed helical portion 172.1 of the connector. In this position of the shield, a small axial gap is provided between the second proximal helical guide portion 112.5 and the first transverse portion 142.2, thereby preventing a purely axial movement in the proximal direction exceeding the gap. Due to the proximal helical movement of the shield, the connector adjacent to the shield has moved further in the proximal direction. Due to the rotational movement of the shield and the connector being rotationally locked by the intermediate guide 144 of the housing, the shield 110 rotates relative to the connector 170, whereby the right-handed helical portion 172.2 slides along the first right-handed helical portion 114.2 and thereby disengages the first left-handed helical portion 172.1 from the abutment with the first left-handed helical portion 114.1 of the proximal guide of the shield.

[0246] from Fig.16H The first intermediate arrangement shown to Figure 16K1 In the unlocked position of the shield shown, the shield is rotated in a proximal helical motion guided by the first distal helical portion 112.8, followed by a pure rotational motion guided by the first transverse portion 112.10. The arrangement for guiding the pure rotational motion is Fig.16J. By the proximal rotational movement of the shield 110 relative to the housing 140, the shield 110 moves relative to the connector 170, and the shield moves the connector relative to the housing. The right-handed helical portion 172.2 slides from the first right-handed helical portion 114.2 along the second right-handed helical portion ( Fig.16H ), until the rear edge of the spiral portion 172.2 reaches the proximal edge of the second right-hand spiral portion ( Fig.16J As the trailing edge passes, a new abutment is established between the second left-handed helical portion 114.4 and the left-handed helical portion 172.1 of the connector as the locking structure 171 of the distal guide of the connector moves into engagement with the locking structure 115 of the proximal guide of the shield ( Figure 16K1 ). Since the left-handed helical portions 114.4, 172.1 of the locking structures 115, 171 abut under the biasing force of the return spring 107, the shield is pushed in the counterclockwise direction, thereby bringing the distal axial guide portion 112.12 into contact with the third axial portion 142.5 of the housing and stopping the rotation. Due to the biasing force and the helical engagement, a releasable locking mechanism is provided. In order to release the lock, a torque exceeding the release threshold torque is required. As previously described, the connector 170 has been simultaneously moved relative to the housing. The connector 170 has been pushed out of the rotation lock together with the intermediate guide 144 of the housing ( Fig.16H ). Thus, the rear edge of the second axial guide portion 174.3 has passed the distal edge of the first axial portion 144.2 of the intermediate guide, whereby the first axial portion 144.2 has been displaced from abutment with the second axial guide portion 174.3 to abutment with the left-handed helical portion 174.4. The connector 170 is guided along the left-handed helical guide portion 174.4 until the click arm 176 of the connector abuts the first axial portion 146.1 of the proximal guide of the housing, as shown Figure 16K1 16K2 shows the relative arrangement of the connector 170 and the transmission tube 180, wherein the corner portion of the connector has been removed. The remaining portion includes the activation tab. The position of the activation tab 178 is indicated by the transverse portion 178.1 and the axial portion 178.2. As shown, the transverse portion 178.1 is adjacent to the transverse portion 183.1 of the protruding tab 183 of the transmission tube. Therefore, the connector 170 is arranged in a position for transmitting force and proximal movement to the transmission tube. Figure 16K3 and K4 show the arrangement of Figure K2 from the opposite side (rotated 180 degrees about the central axial axis). Figure 16K3 As shown, when the shield is arranged in the shield locked state, the connector has translated the transmission tube a small distance in the proximal direction relative to the initial position of the transmission tube, thereby revealing the proximal helical surface portion 157 (see Figure 16K3 ). The initial position of the transmission tube 180 is Fig.13A Shown in. Figure 16K4The injection device is shown in grey scale to provide a better impression of the surface orientation and the extension of the different structures.

[0247] Drug administration status

[0248] The fourth user operation is to push the shield in the unlocked distal position in the proximal direction until it reaches the unlocked proximal position and thereby the device has been changed from the shield unlocked state to the dosing state via a number of intermediate arrangements.

[0249] from Figure 16K1 The shield is unlocked to Figure 16L1 In the first arrangement of the injection device in the dosing state shown, the shield has been pushed in the axial direction from the unlocked distal position to the unlocked proximal position, whereby the activation tab 178 has been pushed through the lateral opening in the outer helical structure 184. By the proximal movement of the shield, the shield has moved the interlocking connector 170. The connector adjacent to the transmission tube 180 has moved the transmission tube 180 from the distal fixed position (wherein the transmission tube is rotationally locked by the housing) to the proximal rotation position (wherein the transmission tube will rotate relative to the housing). By the proximal movement, the torsionally tightened transmission spring 109 has been compressed and brought into a compressed state. From the first arrangement of the device in the dosing state ( Figure 16L1 ) to the last shown arrangement in the dosing state ( Figure 16N1 ), the transmission tube has rotated 360 degrees (i.e., a full rotation) during the distal helical motion and returned to its initial position in the housing ( Fig.13A 13N3), wherein the transmission tube is rotatably locked to the housing and a fixed dose has been expelled thereby. By the rotational movement of the transmission tube, the front edge of the transmission tube having the distal helical surface portion 189 has been moved from Figure 16L3 The starting dosing position shown is advanced in a counterclockwise direction along the proximal helical surface portion 157 of the inner tubular portion 154 of the housing to Figure 16M3 and Figure 16M4 The intermediate shield is shown in an unlocked position, wherein the axial portion 183.2 strikes and abuts against the axial portion 178.2 of the tab 178, as shown in FIG. Figure 16M2 As shown. The transmission tube with the leading edge of the distal helical surface portion 189 continues to perform distal helical motion along the surface portion 157 until it reaches the axial surface portion 156 of the inner tubular portion 154 of the housing. As the compressed transmission spring 108 expands during unwinding, the transmission spring 108 is rotated by the torsion pretensioning force, and the helical surface portion of the transmission tube remains in contact with the helical surface portion 157 of the housing. As a result, the transmission tube has returned to the initial position, which corresponds to the transmission tube having reached the stop dosing position, and further counterclockwise rotation is prevented, as shown in FIG. Fig.13Aand N3. In this position, in response to the release of the axially and proximally directed forces on the shield, i.e., the pressure on the shield tip 119 is released as the device is lifted from the skin, the activation tab 178 is able to move proximally through the transverse opening in the outer helical structure 184. As presented for the drive tube in the start dosing position, the intermediate shield unlocked position and the stop dosing position define three different sets of angular and axial positions: three different angular coordinates and three different axial coordinates.

[0250] Initialization of the automatic relocking mechanism

[0251] During the rotation of the transmission tube 189 from the intermediate shield unlocking position to the stop dosing position, the transmission tube has provided a torque to the connector that exceeds the release threshold torque. Therefore, the locking structure 171 of the connector has been released from the locking structure 115 of the shield, and the connector has rotated until it abuts against the rotation stop provided in the housing. By releasing the locking structures from each other, the automatic shield relocking mechanism has been activated.

[0252] During the counterclockwise rotation, the rear edge of the left-handed helical portion 172.1 moves slightly in the proximal direction along the second left-handed helical portion until it has exceeded the proximal edge of the second left-handed helical portion 114.1. As a result, the connector has shifted from abutment with the left-handed helical portion 114.4 of the shield to abutment with the right-handed helical portion 114.3 of the shield, i.e., abutment between the right-handed helical portion 172.2 of the connector and the second right-handed helical portion 114.3 of the shield has been reestablished. Due to the right-handed helical abutment, the connector is pushed in the counterclockwise direction under the action of the distally directed biasing force of the return spring 107. However, during the rotation of the connector, the connector arm 176 rotates along the first lateral portion 146.2 of the proximal guide of the housing until the angular position of abutment between the axial surface 176.1 of the connector arm and the second axial portion 143.3 of the proximal guide of the housing. Optionally, an additional abutment is provided between the third axial portion 174.5 of the intermediate guide of the connector and the first axial portion 144.2 of the intermediate guide of the housing. Thus, a further counterclockwise rotation of the connector 170 is prevented. Because the shield 110 in this unlocked proximal position is prevented from rotating clockwise due to the abutment between the distal axial guide portion 112.12 of the stepped spiral guide of the shield and the second axial portion 142.3 of the distal guide of the housing, and possibly also due to the optional abutment between the third axial portion 114.8 of the proximal guide of the shield and the second axial portion 144.4 of the intermediate guide of the housing, the connector can only move the shield in the axial direction with a purely axial movement.

[0253] Split-dose prophylaxis

[0254] During activation of the drive tube 180, the connector has moved in a purely proximal axial direction until the activation tab 178 has reached Figure 16L3 184. As previously described, by this movement of the connector, the transmission tube 180 is thereby moved between a distal fixed position (in which the transmission tube is rotationally locked by the housing) and a proximal rotation position (in which the transmission tube rotates relative to the housing due to the torsion provided by the transmission spring 108). By this axial movement, the activation tab has moved through the lateral opening in the helical structure 184, and when the transmission tube reaches the proximal rotation position, the transmission tube begins to rotate and the outer helical structure 184 protruding from the outer surface of the transmission tube rotates to laterally overlap with the activation tab 178, whereby the activation tab and the connector are retained in a position close to the helical structure 184. Figure 16L3 to the stop point (as seen in Figure 16N3 During the rotational movement of the drive tube (as seen in FIG. 1 ), the activation tab 178 is retained proximal to the helical structure 184 of the drive tube, whereby split doses are already prevented. If the pressure is released prematurely, i.e. before reaching the stop dosing position, the connector and the shield move in the distal direction until axial abutment between the distally directed retaining portion 178.3 of the activation tab 178 and the helical structure 184. In the following, if the axial proximal force on the shield is not reestablished, the activation tab will slide along the helical structure 184 when the drive tube is rotated to the stop dosing position, whereby the activation tab will move in a purely distal axial direction through the transverse opening in the helical structure 184.

[0255] Figure 16M1 M4 to M3 show the same arrangement of the injection device 100 . Figure 16M2 With Figure 16M1 The device is shown from the same angle in FIG. 1 , but with a corner portion of the connector cut away. Figure 16M2 and M3 observed from the opposite position (rotated 180 degrees around the central axial axis). Figure 16M4 Shown in grayscale Figure 16M3 The arrangement.

[0256] Figure 16N1 N3 to N4 show the same arrangement of the injection device 100 . Figure 16N2 From Figure 16N1 The device is shown from the same angle in FIG. 1 , but with a corner portion of the connector cut away. Figure 16N2 and N3 observed from the opposite position (rotated 180 degrees around the central axial axis).

[0257] Relock status

[0258] The fifth user operation is to release the axially directed force on the shield by lifting the needle tip 119 from the skin, whereby the shield in the unlocked proximal position moves in the distal direction until it reaches the locked position, and whereby the device has been changed from the dosing state to the relocking state through multiple intermediate arrangements.

[0259] from Figure 16N1 The last placement in the dosing state shown is Figure 16P In the intermediate arrangement shown, the shield 110 has been moved in the axial direction by the connector 170 from the unlocked proximal position to the unlocked distal position, whereby the activation tab 178 has moved through the transverse opening in the outer helical structure 184. Figure 16P The intermediate arrangement shown to Figure 16Q In the intermediate arrangement shown, the connector has the shield rotated in a clockwise direction. Figure 16Q The middle arrangement shown is as follows Figure 16S In the re-locked state shown, the shield has been moved in the distal direction by the connector 170 during clockwise rotation.

[0260] During the distal movement, the right-handed helical portion 172.2 of the connector abuts the second right-handed helical portion 114.2 of the shield. Due to the helical abutment between the connector and the shield, it is pushed in the clockwise direction, whereby the distal axial portion 112.12 is pushed toward the second axial portion 142.3 of the housing. Therefore, in response to further distal movement, the shield is axially guided along the distal guide of the housing until the rear edge of the helical portion 172.2 has reached the distal edge of the second axial portion 142.2, whereby the shield can be rotated in the clockwise direction, as shown in FIG. Figure 16P During clockwise rotation, as indicated by Figures 16P to 16Q As shown in the intermediate arrangement shown, the stepped spiral guide 112 slides between the first transverse portion 142.2 and the transverse portion 162.2, and the connector biases the shield 110 and slides along the proximal guide 114 of the shield. When the rear edge of the first distal transverse guide portion 112.10 reaches the edge between the transverse portion 162.2 and the spiral portion 162.1 ( Figure 16Q ), the shield is movable in a combined distal and rotational movement guided by a connector which moves along the second right-handed helical portion 114.3 to a stationary position adjacent to the first left-handed helical portion 114.1 of the proximal guide ( Figure 16S ).

[0261] During the distal movement of the shield, the connector 170 has moved in the distal direction guided by the first axial portion 144.2 of the intermediate guide of the housing, thereby preventing counterclockwise rotation, as in the last arrangement in the dosing state ( Figure 16N1 )as well as Figure 16Pand Figure 16Q When the leading edge of the left-handed helical portion 174.4 reaches the proximal edge of the first axial portion 144.2, the clockwise rotation of the connector is initiated. During the distal movement, the connector arm or click arm 176 has traveled along the axial guide portions 146.3 and 146.4 and along the ramp portion 146.4 to the flush surface portion 146.5, whereby the click arm 176 has been radially compressed, as shown in FIG. Figure 16Q As the connector 170 moves further in the distal direction, the left-handed helical portion 174.4 slides along the intermediate guide 144 of the housing, which causes a clockwise rotation until the rear edge of the helical portion 174.4 reaches the proximal edge of the first axial portion 144.2. In this position, the connector has almost reached a rest position together with the proximal guide of the shield, wherein the left-handed helical portion 172.1 abuts against the first left-handed helical portion 114.1, and the connector arm has returned to abut against the first axial portion 146.1 of the proximal guide, as shown in FIG. Figure 16R As shown. The connector arm has thus been reset to its initial position and is ready to guide the connector during a new activation and dosing cycle. Figure 16R Arrange in the middle of Figure 16S In the relocked state in , the connector is moved distally into the seat, wherein the first transverse portion 144.1 abuts the first axial portion 174.2, and wherein the axial portions 144.1, 144.2, 174.1 and 174.3 are prevented from rotating.

[0262] Cap covered state Cap locked state

[0263] The fifth user operation is as follows Figure 16T As shown, the cap is covered so that the protrusion 105.2 is inserted into the axial track portion 161.2, thereby being able to rotate it so as to arrange the device in the cap-locked state, which is Fig. 15B (The cap lock status is not displayed in conjunction with the detailed description of the operation). Figure 16T As can be seen above, when the cap is rotated to the locked position, the axially extending rib is positioned to move away from the protrusion 116. Thus, there is no interaction between the cap 105 and the shield 110 when the cap is locked.

[0264] Second embodiment

[0265] Fig.17 26 show a second embodiment of an injection device 200 for delivering multiple fixed doses according to the present disclosure. Fig.17 An exploded view of the injection device is shown, and Fig.18 A cross-sectional view is shown. Fig.18Further details of the various structures and mechanisms are shown in Figures 23. Figures 25-26 show in detail the interrelationship of the mechanical structures during operation.

[0266] Fig.17 Shown are the cap 205 , the shield tip 219 , the shield rear part 220 . 1 of the cleaning module further comprising a movable part, which corresponds to the movable part 120 . 2 in the first embodiment 1 . Fig.17 Also shown are: a needle hub 225 with a needle cannula 224; a tubular elongated housing structure 240; and a housing cap portion 260 to be connected at the distal end of the housing structure 240. The figure also shows a tubular elongated needle shield structure 210, a cartridge holder 230, a cartridge 235, a connector 270, a shield return spring 207, a transmission tube 280, a dose transmission spring 208, a piston rod 209, and a spring base 265. The figure also shows a piston washer 204, which includes a ratchet arm and an external thread for engaging a toothed ring and an internal thread at the inner surface of the piston rod 209, respectively, thereby enabling a zero adjustment relative to the piston in the cartridge 235. Fig.18 A cross-sectional view of the injection device 200 is shown, wherein the injection device is in an unpacked state. The cross-sectional plane passes through the window 211 of the shield.

[0267] Housing components

[0268] The injection device comprises a housing assembly which provides a rigid frame and has guides and connectors for guiding and connecting the other components of the device. The housing assembly comprises a housing cap portion 260, a tubular elongated housing structure 240, a cartridge holder 230 having a window 231, and a spring base 265. After final assembly, these structures are fixedly connected, and the housing assembly can provide a reference frame for describing the relative motion and position of the other structures. The elongated housing structure 140 comprises an internal thread 254.3 for engaging an external thread of the piston rod.

[0269] The injection device 200 comprises a transmission mechanism and a trigger or activation mechanism. The transmission mechanism comprises a piston rod 209, a transmission spring 208 and a transmission tube 280, and these structures are operatively arranged in the housing for expelling a dose. The trigger mechanism comprises an elongated shield structure 210 and a connector 280, and these structures are operatively arranged in the housing for triggering the dose expelling mechanism.

[0270] The tubular portion 254 includes an intermediate guide 244, which includes: an outer axial portion 244.1, which is symmetrically arranged around the longitudinal axis at a first radial position and thereby defines a first diameter; and an inner axial portion 244.2, which is symmetrically arranged around the longitudinal axis at a second radial position and thereby defines a second diameter.

[0271] Needle Shield Assembly

[0272] The injection device further comprises a needle shield assembly comprising a shield tip 219 and an elongated shield structure 210. The elongated shield structure 110 comprises a window 211 for inspecting the drug, the elongated shield being arrangable in a first position overlapping with the cartridge holder window 231 and in a second position without overlap, wherein a solid portion of the elongated shield structure covers the window 231 in the second position.

[0273] Cartridges and Cartridge Holders

[0274] The cartridge holder 230 is adapted to receive a cartridge 235. The cartridge holder includes a window 231 for inspecting the medicament in the cartridge 235. The cartridge 135 and the cartridge holder 230 are similar in structure and function to the cartridge 135 and the cartridge holder 130 of the first embodiment, respectively.

[0275] Needle Assembly

[0276] The needle assembly including the needle hub 225 and the needle 224 is similar in structure and function to the needle assembly of the first embodiment.

[0277] Blocked Shots

[0278] The cap 205 is adapted to be releasably mounted to the housing cap portion 260. The cap includes an inner surface having a protrusion adapted to couple with the bayonet coupling track. The inner surface of the cap 105 also includes an axially extending rib (not shown) that protrudes from the inner surface and is adapted to transfer torque to the shield structure 110 through the axially extending ribs 216 on the outer surface of the shield. The cap 205 is similar in structure and function to the cap 105 of the first embodiment, but differs in that the cap 205 also encloses the shield and the main portion of the barrel.

[0279] Spring base

[0280] The spring base 265 is fixedly mounted to the housing structure 240 at the proximal end and is adapted to receive and support the compressible torsion transmission spring 108 .

[0281] Transmission spring

[0282] The transmission spring 208 is pre-tensioned or coiled and is positioned between the spring base and the transmission tube 280. The transmission spring is also adapted to induce a torque on the transmission tube, thereby enabling the discharge of the medicament. The transmission spring includes torsion and compressible sections. The ability to drive the transmission tube in the axial direction enables the end point of the dose mechanism and enables the resetting of the transmission tube.

[0283] Return spring

[0284] The connector return spring 207 is positioned between the spring base 265 and the relocking tube 279 and is adapted to push the relocking tube in the distal direction. In the return arrangement, the relocking tube 279 abuts the shield 210 and the shield engages the connector, whereby the shield 210 and the connector 270 can be returned together with the relocking tube 279.

[0285] Cleaning components

[0286] The cleaning assembly is similar in structure and function to the cleaning assembly of the first embodiment.

[0287] Shell structure

[0288] Fig.19 A perspective view of features disposed at the inner surface of the tubular housing structure 240 is shown with an axial cut-away view of the housing. Fig.19 As seen in FIG. 2 , the tubular housing structure 240 includes an outer tubular portion 243 and an inner tubular portion 254. In the example shown, the inner tubular portion 254 is integrally connected to the outer tubular portion. The outer tubular portion includes an outer surface having an outer diameter and an inner surface having an inner diameter, wherein the outer tubular portion is adapted to accommodate the transmission assembly and the relock tube 279.

[0289] The housing structure 240 comprises a guide structure comprising an axial surface portion 256 providing a sliding surface and a rotation stop, and a helical surface portion 257 providing a sliding surface suitable for guiding the drive tube 280 during administration.

[0290] Fig. 20 The inner tubular portion 254 is shown in detail in a perspective view, wherein the outer tubular portion 243 has been cut away. The inner tubular portion comprises: a tubular transmission tube engagement portion 254.1 for accommodating the distal portion of the transmission tube; and a tubular drive piston rod engagement portion 254.2, which comprises threads 254.3 for threadedly engaging the piston rod 209. The piston rod engagement portion also comprises a connector 254.4 for snap-fit ​​connection with the cartridge holder 230.

[0291] Zero point adjustment mechanism

[0292] like Fig.17 As seen in FIG. 1 , similar to the method described for the first embodiment, the piston gasket includes external threads and a ratchet arm for cooperating with threads and a toothed ring on the inner surface of the piston to achieve zero point adjustment.

[0293] Transmission mechanism

[0294] The construction and function of the transmission mechanism of the second embodiment are similar to those of the first embodiment. In particular, the transmission tube 280 is axially splined to the piston rod. Fig.23A and Fig. 23B The transmission tube 280 is shown in perspective from different angles. As seen in Figure 23, as a difference from the first embodiment, the transmission tube 280 of the second embodiment includes a closed guide 284, which includes a first lateral portion 284.1, a right-handed spiral portion 284.2, and a left-handed spiral portion 284.3. The lateral guide portion 284.1 includes a proximal directional surface providing a connector seat, wherein the connector is placed before and after the transmission tube is activated. The lateral portion also includes an abutment structure 283, which includes a distal directional surface portion 283.1, which provides an abutment surface for abutting the connector during activation. The right-handed spiral portion 284.2 includes a distal surface that provides an abutment surface for the connector in response to premature release of the shielding pressure, i.e., a split dose prevention feature. The left-handed spiral portion 284.3 provides a ramp surface for rotating the connector at the end of the dose, thereby initiating the reset of the shield. For the first embodiment 100, the transmission tube of the injection device 200 includes a guide structure, which includes: an axial surface portion 282 adapted to slidably engage the axial surface portion 256 of the housing in a rotational locking arrangement; and a helical surface portion 289 adapted to slidably engage the helical surface portion 257 of the housing during administration.

[0295] The same considerations for incorporating a torsion spring into the transmission mechanism in the second embodiment provide the same advantages as mentioned for the first embodiment.

[0296] Slim shield structure

[0297] Fig.24 A perspective view of a cylindrical elongated shield structure 210 is shown. The proximal portion of the shield is to be disposed within a connector 270, which in turn is to be disposed within housing portions 240, 260. The elongated shield structure 210 comprises a tubular portion comprising an outer surface having an outer diameter and an inner surface having an inner diameter. Axially extending ribs 216 are positioned at the distal end protruding from the outer surface. The ribs are adapted to cooperate with internal ribs of the cover 205.

[0298] The shield structure 210 further comprises radial guides 212 which are arranged at the proximal end and extend radially, whereby the shield is adapted to cooperate with the connector 270 .

[0299] The elongated shield structure 210 also includes a proximal guide 214 positioned at the proximal end of the shield structure 210. Fig.24214. The proximal face of the proximal guide can be seen. The proximal guide 214 is adapted to cooperate with the connector 270 and the relocking tube 279. The proximal guide 214 extends in the axial and circumferential directions and comprises a first transverse portion 214.1, an axial portion 214.2, a right-handed helical portion 214.3 and a second transverse portion 214.4. The proximal guide 214 also comprises a cutout 214.5 which provides a rotational lock for locking the shield in a shield starting state in which it cannot return to an unpacked state. The cutout provides a right-handed helical guide portion 214.6. The guide portions 214.1 to 214.4 are all surface portions that provide the proximal face of the proximal guide 214.

[0300] Connectors

[0301] Fig. 22 A perspective view of a connector 270 to be arranged within the tubular housing parts 240, 260 and between the elongated shield structure 110 and the transmission tube is shown. The connector 270 is adapted to establish a connection between the shield 210 and the transmission tube 280 and to activate the transmission tube 280. The connector 270 comprises a distal guide 272 adapted to cooperate with the proximal guide 114 of the shield. The distal guide 272 extends in the circumferential direction and comprises a transverse surface portion 272.1 as a distal orientation surface.

[0302] The connector also includes a stepped spiral track 274 for cooperating with the radial guide 212 of the shield. The stepped spiral track includes a distal transverse portion 274.1, a distal spiral portion 274.2, an intermediate transverse portion 274.3, a proximal spiral portion 274.4, and a proximal transverse portion 274.5. Due to the spiral portion of the stepped spiral track, the rotational movement of the shield 210 can be transmitted to the proximal movement of the shield, and due to the transverse portion of the stepped spiral track 274, the distal directional force on the shield can be transmitted to the connector 270, whereby the shield can move distally. If the shield applies a distal force to the spiral portion of the stepped spiral track 244, the connector can move distally or move distally and rotationally.

[0303] The connector 270 comprises a first tubular portion 270.1 having a full 360 degree circumference and a second tubular portion 270.2 having two cutouts, whereby the remaining portion of the second tubular portion forms two axially extending tubular portions 276. The first tubular portion comprises a stepped helical track 274, and the two axially extending tubular portions 276 comprise: a distal transverse surface 272.1 forming a distal guide 272; a first axial surface providing a first axial guide 276.1; and a second axial surface positioned clockwise from the first surface, the second axial surface providing a second axial guide 276.2. The shield can be arranged within the first tubular portion 270.1 having a radial guide 212 extending through the stepped helical track 274. The axially extending tubular portion 276 extends from the inner surface of the first tubular portion 270.1 in the proximal direction and therefore has a smaller diameter. The transverse surface portion 272.1 is arranged on the distal oriented surface of the axially extending tube portion 276, and the proximal guide 214 having the proximal oriented surface is adapted to cooperate with the transverse guide portion 272.1 when the diameter of the tube portion 276 corresponds to the diameter of the shield 210. The diameter of the axially extending tube portion 276 also corresponds to the diameter of the inner axial portion 244.2 of the intermediate guide, whereby the axially extending tube portion 276 can cooperate with the inner axial portion 244.2. The connector 270 has an outer surface with an outer diameter and an inner surface with an inner diameter. Fig.18 As shown, which is a cross-sectional view of the injection device 200, the outer surface of the first tubular portion 270.1 of the connector is arranged in close proximity to the inner surface of the tubular housing cap portion 260. The axially extending tube portion 276 surrounds the inner tubular portion 254 of the housing and the transmission tube 280. The axially extending arm 276 is also adapted to cooperate with the intermediate guide 244.1 of the housing to guide the movement of the connector relative to the housing.

[0304] The connector 270 further comprises an activation tab 278 disposed at the proximal end of the axially extending tube portion 270.2 and extending radially from the inner surface in a negative radial direction (i.e., toward the center of the tubular portion). The activation tab 278 extends into the closed rail 284 of the transmission tube. The activation tab 278 comprises a first transverse portion 278.1 providing a proximal directed contact surface adapted to engage a distal directed surface 283.1 of an abutting structure in the transverse portion 284.1 of the closed rail, thereby enabling the transmission tube 280 to be proximally moved and activated. The activation tab 278 further comprises a proximal directed surface portion 278.2 adapted to engage a distal directed surface of the closed rail 284, whereby the connector can be guided during a dose cycle and whereby a split dose can be prevented in response to a premature release of proximal pressure on the shield. The shield relocking mechanism is activated in response to the proximal end portion 278.2 of the activation tab being guided along the left-handed helical guide portion 284.3.

[0305] Re-lock tube

[0306] The relocking tube 279 comprises a first tubular portion 279.1 and a second tubular portion having two cutouts, whereby the remainder of the second tubular portion forms two axially extending tubular portions 279.2. The relocking tube comprises an axially extending guide rail 279.4 extending from the proximal end to the distal end at a relatively small distance (e.g., 1 / 10 of the length of the relocking tube). The two axially extending tubular portions 279.2 comprise: an axial guide portion 279.5, a first transverse guide portion 279.6, a right-handed spiral portion 279.7, and a second transverse portion 279.8. The axially extending tubular portion 279.2 also comprises an axial portion 279.9, which provides a rotation stop and an axial guide for the connector. The axially extending tubular portion 279.2 extends from the inner surface of the first tubular portion 279.1 in the proximal direction and therefore has a smaller diameter. The spiral portion and the transverse guide portions 279.6 to 279.8 are arranged on the distal directional surface of the axially extending tube portion 279.2, and the proximal guide 214 having a proximal directional surface is suitable for cooperating with the spiral portion and the transverse guide portions 279.8 to 279.8 when the diameter of the tube portion 279.2 corresponds to the diameter of the shield 210. The diameter of the axially extending tube portion 279.2 also corresponds to the diameter of the inner axial portion 244.2 of the intermediate guide. The diameter of the first tubular portion corresponds to the diameter of the outer axial portion 244.1 of the intermediate guide. The axially extending guide rail 279.4 is suitable for cooperating with the outer portion 244.1 of the intermediate guide rail, whereby the relocking tube 279 is rotationally locked and axially guided between the distal position and the proximal position defined by the proximal end of the guide rail 279.4 ( Fig.18They are shown to be axial play between the outer portion 244.1 and the proximal end of the track). The relocking tube 279 has an outer surface with an outer diameter and an inner surface with an inner diameter. Fig.18 As shown, the outer surface of the first tubular portion 279.1 of the relocking tube is arranged in close proximity to the inner surface of the outer tubular portion 243 of the housing, and the return spring is positioned between the spring base 265 and the proximal edge of the relocking tube 279, whereby the relocking tube can be biased distally in response to the proximal movement. The axially extending tube portion 279.2 surrounds the inner tubular portion 254 of the housing and is capable of cooperating with the axially extending tube portion 270.2 of the connector.

[0307] Detailed description of the device operation

[0308] 25A to 26B collectively illustrate the relative and functional arrangement of the various structures of the injection device 200 during a series of states, thereby illustrating the operation of the device in detail.

[0309] In one embodiment of the present disclosure, an injection device 200 for sequentially delivering multiple fixed doses comprises: a housing comprising an elongated housing structure 240, a barrel holder 230 and a housing cap portion 260; an internal thread; a shield comprising an elongated shield structure 210 and a needle tip 219; a needle hub 225 comprising a fixedly attached needle cannula 204; a cap 205 removably mounted on the housing and adapted to cover a major portion of the shield; a barrel 235 having a movably arranged barrel plunger or piston 236 and a transmission mechanism comprising a torsion transmission spring 208; a transmission tube 280; and a piston rod 209 having an external thread for cooperating with the internal thread of the housing, the piston rod being arranged to be connected to the piston 236, and wherein the torsion spring is adapted to provide a torque for rotating the transmission tube 280 relative to the housing. The transmission tube comprises a ratchet mechanism 281, 265.1, thereby ensuring rotation in the dosing direction and blocking in the non-dosing direction. The transmission tube is axially splined with the piston rod, thereby allowing relative axial movement and preventing relative rotation. The transmission tube is suitable for advancing the piston rod in response to rotating the transmission tube in the dosing direction, and due to the threaded connection with the housing, the piston rod is suitable for advancing the piston 236 in the cylinder 235 to discharge a fixed dose. The transmission mechanism is suitable for activating by changing the transmission tube from the distal position (wherein the transmission mechanism is in a fixed mode) to the proximal position (wherein the transmission mechanism is in a dosing mode). At the distal position, the transmission tube is rotationally locked to the housing. At the proximal position, the transmission tube is rotationally unlocked with the housing, and the torque provided can make the transmission tube rotate a predetermined angle to discharge a fixed dose. In the fixed mode of the transmission mechanism, the piston rod rotates and axially locks, and the piston rod is rotationally locked to the housing by being connected to the spline with the transmission tube 280, and is axially locked by being threadedly connected with the housing.

[0310] The torsion spring 208 is pre-tensioned to deliver multiple doses without binding during use.The transmission mechanism is adapted to change modes immediately after activation and, as explained later, is adapted to be repeatedly activated until the last dose has been expelled.

[0311] The cap can be arranged in an axially locked position and an axially unlocked position. The cap can be changed between the positions by rotating the cap relative to the housing. With the cap in the axially unlocked position, the cap can be removed from the housing.

[0312] The shield can be arranged in different positions. The initial position is defined by the initial angular position and the corresponding initial axial position. The unengaged position is defined by the unengaged angular position and the corresponding unengaged axial position. The engaged distal position is defined by the engaged angular position and the corresponding distal engaged axial position. The engaged proximal position is defined by the engaged angular position and the corresponding proximal engaged axial position. In the initial position, the shield is adapted to allow counterclockwise movement. In the unengaged position, the shield is adapted to prevent clockwise movement and allow clockwise movement. The shield is not engaged with the connector because the proximal movement of the shield is not transferred to the proximal movement of the connector, whereby the shield cannot activate the transmission tube in this position. In the engaged distal position, the shield is adapted to prevent counterclockwise and distal movement of the shield, and is also adapted to allow proximal movement. In the engaged distal position, the shield is also adapted to allow clockwise rotation when the applied torque exceeds a predetermined threshold. For the shield in the initial position and the unengaged position, the needle tip is covered by the shield. In the engaged position, the shield is adapted to move from an engaged distal position (wherein the needle tip is covered by the shield and where pressure in the reservoir can be released) to a proximal engaged position (wherein the needle tip extends away from the shield and can be inserted into the subcutaneous layer of the subject). In this position, further proximal movement can be prevented by the shield tip 119 being blocked against the needle hub 125. The shield can be manually operated by a user between different positions. As presented for the shield in the initial position, the unengaged position, the distal engaged position, and the proximal engaged position define four different sets of angular and axial positions: three different angular positions and four different axial positions.

[0313] The connector can be arranged in an initial or first position defined by a first angular position and a corresponding distal position, wherein the connector is allowed to move along the rotationally locked relock tube 279 to a proximal position until the connector 270 engages an axial stop on the housing or the shield tip 219 abuts the seat 225. Thus, the connector can also be arranged in a second position defined by the first angular position and the proximal position. Even further, the connector can be arranged in a third position defined by a second angular position and a corresponding distal position, wherein the first position and the third position are defined by the same axial position.

[0314] 25A to 26B collectively show a portion of an injection device 200 arranged in different states and intermediate arrangements, wherein an outer portion of the housing and the entire cap have been cut away to show some of the internal structure. Each illustrated state is illustrated with some of the internal components hidden by the connector and the relocking tube, such as 25B1, and each illustrated state is illustrated with an outer portion of the relocking tube and a portion of the outer portion of the connector removed, such as 25B3. Grayscale illustrations of some of the illustrated states are also provided, such as 25B2 corresponding to 25B1 and 25B4 corresponding to 25B3.

[0315] Unpacking status

[0316] 25A illustrates a portion of the injection device 200 in an unpacked state and shows the shield structure 210 , the cartridge holder 230 , the connector 270 , the drive tube 280 and the return spring 207 , the relock tube 279 and the spring base 265 . Fig.25A1 Parts of the injection device are shown in black and white, and Fig.25A2 Identical dimensions are shown in grey to better illustrate the different components of the construction.

[0317] Cap unlocked state

[0318] The first user operation is to rotate the cap counterclockwise until it reaches the axial unlocked position, whereby the shield changes from the initial position to the unengaged position, and whereby the device changes from the unpacked state to the cap unlocked state, such as Figure 25B1and B2. The cap can be moved axially in the cap unlocked state. The cap unlocked state is also referred to as the shield activated state because the shield has activated the device, or as the unengaged shield state because the shield is not engaged with the connector to activate the device, or as the inactive state because the shield cannot activate the transmission mechanism. Compared with embodiment 100, the shield 210 in embodiment 200 is not necessarily axially locked to the housing in this state, but since the shield does not engage the connector, the axial movement cannot be transmitted from the shield to the connector, and the connector cannot move to activate the transmission tube 280. When the radial guide 212 of the shield engages the stepped spiral track 274 of the connector 270, during the proximal spiral movement of the shield from the initial to the unengaged position, the radial guide 212 abuts the proximal surface of the distal spiral guide portion 274.2 of the stepped spiral track. In the unengaged position, the radial guide rests on the middle transverse portion 273.4, wherein there is no proximal side on the track 274. During the proximal helical movement of the shield, the shield has moved the relocking tube 279 proximally against the biasing force of the return spring 208, and in the unengaged position, the axial extension 279.2 of the relocking tube has moved into the cutout 214.5, thereby providing a rotational lock. For the shield in the unengaged position, the right-handed helical portion 279.7 of the relocking tube abuts the right-handed helical guide portion 214.6 of the cutout and the right-handed helical portion 214.3 of the proximal guide, thereby pushing the shield in the distal direction. The distal force is transmitted from the shield to the connector through the abutment between the radial guide 212 and the track 274, whereby the connector is also biased in the distal direction. Therefore, in the following state, the relocking tube 279, the shield 210 and the connector are biased toward the distal end. It is presented on Figure 25B that the shield does not extend to the spring base and is therefore not compressed. However, although the illustrated embodiment is slightly inaccurate, the shield is at least slightly compressed in this state. Otherwise, the component will rock toward the inside of the unit when turning from top to bottom and vice versa.

[0319] Cap off state

[0320] The second user operation is to pull the cap out in the distal direction, whereby the device changes from the cap-unlocked state to the cap-disengaged state.

[0321] Since the cap is not shown in FIGS. 25A to 26B , Figure 25B1 and B2 also show the cap detached state.

[0322] Shield engaged or activated

[0323] The third user operation is to rotate the shield counterclockwise to a disengaged or inactive position (due to the inability to activate the transmission mechanism) until it reaches an engaged distal or activated position and the device has thereby changed from a cap disengaged state to a shield unlocked state.

[0324] From the shield unengaged position to Fig.25C1 With the shield engaged in the distal position shown in C2, the shield is rotated with a proximal helical movement guided by the distal helical portion 274.4, followed by a pure rotational movement guided by the proximal transverse portion 274.5. During the proximal helical movement of the shield along the distal helical portion 274.4, the right-handed helical guide portion 214.6 of the cutout and the right-handed helical portion 214.3 of the shield with the right-handed helical portion 279.7 of the relocking tube slide in abutment, whereby the rotationally locked relocking tube 279 is forced in the proximal direction. During the pure rotational movement of the shield, the abutment between the helical portion 279.7 of the relocking tube and the helical portions 214.7, 214.3 of the shield is only displaced to the abutment between the right-handed helical portions 214.3, 279.7, and then to the abutment between the second transverse portion 214.4 of the proximal guide and the first transverse guide portion 279.6 of the relocking tube. When the abutment surface between the second lateral portion 214.4 of the shield and the first lateral portion 279.6 of the relocking tube extends in a direction orthogonal to the biasing force of the return spring, the abutment provides a static position of the relocking tube 279 and the shield 210. Due to the biasing force and the abutment between the lateral portions 214.4, 279.6, a releasable locking mechanism is provided between the shield 210 and the relocking tube 279. In order to release the lock, a torque exceeding a release threshold torque is required. During the helical movement of the shield, the first lateral surface portion 214.1 of the proximal guide of the shield and the lateral surface portion 272.1 abut, and during pure rotation, the shield slides relative to the connector until abutment between the axial portion 276.1 of the axial extension 276 and the axial portion 214.2 of the proximal guide. Thus, releasing the lock and thereby establishing abutment between the helical portion 214.3, 279.7 of the shield and the relocking tube will also disengage the shield transverse portion 214.1, 272.1 and the connector. The other axial portion 276.2 of the axially extending tube portion 276 of the connector is rotationally locked in the counterclockwise direction relative to the rotationally locked axial portion 279.9 of the relocking tube, which is slidably arranged with the intermediate guide 244 engaged in the axial track 279.4. The activation tab 278 of the connector is located in the transverse portion 284.1 of the closed guide in the transmission tube. In the engaged distal position, the shield is adapted to move the connector in the proximal direction to activate the transmission tube.

[0325] Drug administration status

[0326] The fourth user operation is to push the shield in the engaged distal position in the proximal direction until it reaches the engaged proximal position and thereby the device has changed from the shield unlocked state to the dosing state. The dosing state is illustrated by the arrangement shown in Figures 25D to 25E.

[0327] From the distal position where the shield engages to Fig.25D1 and the proximal position of the shield engagement shown in D2, the shield moves in a proximal and purely axial movement guided by the relocking tube traveling along the intermediate guide 144. During the proximal movement of the shield, the engaged relocking tube 179 translates proximally to further compress the return spring 208, and the connector engaged by the shield translates proximally, thereby activating the tab 278 to engage the proximal surface of the transverse portion 284.1 of the closure rail, and wherein the transmission tube also translates proximally. As a result, the transmission tube has moved from the distal position, wherein the transmission tube is rotationally locked to the housing, to the proximal position, wherein the transmission tube is rotationally unlocked from the housing. As shown in FIG. Fig.25D2 As shown, the torque provided by the transmission spring 207 has caused the transmission tube to rotate, thereby activating the tab has slid out of the transverse portion 284.1 and into the right-handed spiral portion 284.2 of the closed guide. FIG. 25D also shows the axial portion 257 (see FIG. 25D ) of the inner tubular portion 254 for abutting the housing. Fig.19 )'s axial portion 282, and a spiral portion 256 of the housing for adjoining a spiral portion 289 of the transmission tube (see FIG. 23).

[0328] 25E shows another arrangement in the dosing state, subsequent to the arrangement in 25D, wherein the transmission tube 180 has been further rotated during dosing, and thereby the activation tab 278 is arranged at the proximal end of the right-handed helical portion 284.2, wherein the abutment zone will change from the right-handed helical portion 284.2 to the left-handed helical portion 284.3. As in the previous state, the connector abuts the axial portion 114.2 of the proximal guide of the shield, and the first lateral guide portion 279.6 of the relocking tube abuts the second lateral portion 214.4 of the proximal guide of the shield to transmit the axial distal force from the relocking tube 279 to the connector 270 through the shield 210.

[0329] Initialization of the automatic relocking mechanism

[0330] When the transmission tube stops rotating by reaching the end of the dose, the proximal portion 278.2 of the activation tab 278 disengages from abutment with the right-handed helical track, whereby the connector is no longer blocked from moving in the distal direction. Since the transmission tube does not block axial movement of the connector, the connector will move axially in the distal direction and rotate in response to releasing pressure from the shield, whereby the connector will move into engagement with the left-handed helical portion 184.3 of the transmission tube. Thus, the automatic relocking mechanism has been activated.

[0331] Split-dose prophylaxis

[0332] During the dosing cycle, the activation tab 278 engages in the closed guide 284. Therefore, in response to lifting the shield from the skin, before the dose is completed, the activation tab will be blocked by the first transverse portion 284.1 or the right-handed spiral portion 284.2 of the guide 284, and the transmission tube will continue to rotate until the dose is completed. When the rotation is completed, the connector will push the connector to the distal end together with the activation tab and the shield, but the dose is prevented from being split or interrupted, thereby ensuring that the next dose can be taken correctly. If the shield is extended to the distal position, the needle tip will be placed in the clean room, thereby generating an overpressure in the clean room. The overpressure can inadvertently stop the dosing.

[0333] Relock status

[0334] The fifth user operation is to release the axially directed force on the shield by lifting the needle tip 219 from the skin, whereby the shield moves in the distal direction in the engaged proximal position until it reaches the unengaged position, and the device has thereby changed from the dosing state to the unengaged state or non-actuated state shown in Figure 25G via the intermediate arrangement shown in Figure 25F.

[0335] Automatic relocking mechanism

[0336] FIG. 25F shows an intermediate arrangement between the dosing state and the unengaged state shown in FIG. 25G , in which the transmission tube has been rotated into abutment with the axial portion 257, whereby the dose is completed. During the rotation of the transmission tube, and in response to the release of pressure from the shield, the activation tab 278 has been displaced to abut against the left-handed helical portion 284.3, and due to the compression from the return spring 207, the activation tab 278 has been forced to move along the left-handed helical track, and thereby the connector 270 is rotated and axially moved to the second angular and distal position. The force of the compression spring is transmitted from the recombinant tube to the connector through the shielding device. During the rotation of the connector, the shield has been rotated due to the abutment between the axial portion 214.2 of the proximal guide of the shield. Due to the rotation of the shield, and when the relocking tube is rotationally locked, the abutment between the shield and the relocking tube has been displaced to the abutment between the right-handed helical portion 214.3 of the shield and the right-handed helical guide 274.7 of the relocking tube. The helical abutment surface allows the axial movement of the relock tube 279 to be transferred into the rotational movement of the shield, and when the relock tube is biased distally, the relock tube moves distally and the shield rotates to the unengaged position, whereby the first transverse portion 214.1 of the locking structure 215 of the shield moves away from the abutment together with the transverse portion 272.1 of the distally directed transverse guide portion 272. Since the two transverse portions 214.1, 272.1 are transverse, they can be forced to slide apart in response to the application of relative rotation.

[0337] Cap covered state Cap locked state

[0338] A fifth user operation is to open the cap, not shown for the injection device 200, whereby a protrusion on the inner surface of the cap is inserted into an axial track portion on the housing, whereby the axial track portion can be rotated to place the device in the cap locked state. The cap locked state for the injection device 200 is not shown. When rotated back to the locked state, the cap 205 does not engage the shield and therefore the shield is not pushed towards the initial position.

[0339] 26A and 26B show two arrangements when taking a second dose or more doses, if the connector is not rotated back to its first position. When the relocking tube is moved to its distal position, the connector 270 can remain in the third position, with the connector 270 being rotated back to its first position. Figure 25G2 25B, or it may be forced by the shield 210 to rotate with the first angular position to the first position as the radial guide slides distally along the proximal helical guide 274.4. In the latter case, a new dose will start from the arrangement shown in FIG. 25B. In the first case, a new dose will start from Figure 25G2The arrangement shown in FIG. 26A begins, and continues with the arrangement shown in FIG. 26A , in which the shield pushes the relocking tube in the proximal direction until the axial portion 214.2 of the shield abuts the axial extension 270.2 of the connector. In response to further rotation, the connector is pushed back to the first position, in which the first angular position is shown in FIG. 26 . From here, the next dose continues as described in FIG. 25C .

[0340] Additional Implementation

[0341] The additional alternative embodiments described are not shown separately and are not provided with reference numerals. However, the features of the alternative embodiments correspond to the features of the illustrated embodiment, whereby the features of the alternative embodiments provide one or more functions similar or equivalent to the features of the illustrated embodiment.

[0342] In an alternative embodiment, a drug delivery device for delivering a predetermined fixed dose is provided, wherein the drug delivery device comprises:

[0343] - housing assembly,

[0344] -Drug reservoir with piston

[0345] - a transmission mechanism comprising: a piston rod for advancing the piston to expel the drug; and a transmission tube, wherein the transmission mechanism is adapted to deliver the predetermined fixed dose in response to activation;

[0346] - an activation mechanism for activating the transmission mechanism in response to moving the transmission tube in an axial direction,

[0347] wherein the housing assembly comprises a guide structure for guiding the drive tube during activation and delivery of a dose, wherein the guide structure comprises: an axial portion providing a sliding surface, the sliding surface of the axial portion being used to guide the drive tube during activation and for providing a rotational stop defining an end point of a dose, and a helical portion providing a sliding surface, the sliding surface of the helical portion being suitable for guiding the drive tube during administration;

[0348] The transmission tube includes a guide structure, the guide structure including an axial portion, the axial portion is suitable for slidably engaging the axial portion of the housing assembly for activation; and a spiral portion, the spiral portion is used to slidably engage the spiral portion of the housing assembly during administration.

[0349] A drug delivery device is provided herein, wherein the transmission mechanism comprises a helical guide portion and an axial guide portion to provide a fixed dose immediately upon activation.

[0350] The helical portion of the housing assembly corresponds to the helical portion 157, 257 of the housing of the first and second embodiments, and the axial portion of the housing assembly corresponds to the axial portion 156, 256 of the housing of the first and second embodiments. The transmission tube, the torsion transmission spring, and the piston rod correspond to the transmission tube 180, 280, the torsion transmission spring 108, 208, and the piston rod 109, 209. The axial portion of the transmission tube corresponds to the axial portion 182, 282 of the transmission tube of the first and second embodiments, and the helical portion of the transmission tube corresponds to the helical portion 189, 289 of the transmission tube of the first and second embodiments.

[0351] In an alternative embodiment, the guide structure of the housing assembly is a closed guide providing a duty cycle for the drive tube, and wherein the starting position of the drive tube and the end of the dosing position are the same.

[0352] In an alternative embodiment, the housing assembly further comprises internal threads, wherein the piston rod comprises external threads engaging the internal threads of the housing assembly.

[0353] In an alternative embodiment, the transmission tube is axially splined to the piston rod.

[0354] In an alternative embodiment, the transmission mechanism further comprises a motor mechanism for rotating the transmission tube in response to activation of the transmission mechanism for delivering a dose. The transmission tube is axially splined to the piston rod, whereby the transmission tube is rotationally locked relative to the piston rod. The transmission mechanism further comprises a return mechanism for moving the transmission tube in an axial direction after activation, thereby returning the transmission tube. Here, the transmission tube is reset in an initial position after activation.

[0355] In an alternative embodiment, the trigger mechanism includes a movably arranged connector, wherein the connector includes an activation tab, and wherein the activation tab is adapted to engage a surface portion of the transmission tube in response to moving the connector in an axial direction, whereby the connector is operatively connected to the transmission mechanism and adapted to trigger the transmission mechanism, wherein the surface portion is oriented in a direction toward the activation tab.

[0356] The connector and the activation tab correspond to the connector 170, 270 and the activation tab 178, 278 of the first and second embodiments. The surface portion corresponds to the distally directed surface 183.1, 283.1 of the first and second embodiments.

[0357] In an alternative embodiment, the drug delivery device comprises:

[0358] a fixed state, wherein the transmission tube is arranged in a first axial position and a first angular position, wherein the transmission tube is locked to the housing, wherein the guide structure of the transmission tube abuts the axial portion of the housing assembly and the helical portion of the guide structure of the housing assembly,

[0359] a first dosing state, in which the transmission tube is arranged in a second axial position and in the first angular position, whereby the transmission mechanism is activated, and

[0360] - a second dosing state, wherein the spiral portion of the guide structure is slidably arranged along the spiral portion of the guide structure of the housing assembly, whereby a dose can be expelled.

[0361] In an alternative embodiment, in response to moving the connector from a first axial position to a second axial position, the connector is adapted to move the transmission tube between the first axial position and the second axial position, thereby changing the drug delivery device from the fixed state to the first dosing state, and wherein in response to setting the injection device in the first dosing state, the transmission mechanism is adapted to rotate the transmission tube, thereby changing the injection device from the first dosing state, through the second dosing state, to the fixed state.

[0362] wherein the first position and the second position of the connector are different from the first position and the second position of the transmission tube,

[0363] The axial distance between the first position and the second position of the connector is greater than or equal to the axial distance between the first position and the second position of the transmission tube.

[0364] In an alternative embodiment, the motor mechanism includes a torsion transmission spring for rotating the transmission tube by unwinding, wherein the transmission spring is fixed between the housing assembly and the transmission tube, and wherein the transmission spring is also compressible for moving the transmission tube distally during rotation, whereby the transmission spring provides the return mechanism for returning the transmission tube after activation.

[0365] In an alternative embodiment, the transmission spring comprises a compressible section, wherein the compressible section corresponds to the compressible section 108 . 4 of the first and second embodiments.

[0366] In an alternative embodiment, the activation tab comprises a transverse surface portion and wherein the engageable surface portion of the drive tube is transverse, whereby initiation of drug administration is provided by rotational movement caused by the torsion drive spring.

[0367] In an alternative embodiment, the drug delivery device comprises a spring base, which is arranged rotatably relative to the housing assembly, wherein a one-way ratchet mechanism is provided between the rotatably arranged spring base and the housing assembly, whereby the spring can be tensioned by rotating the spring base. Here, instead of being tensioned or in addition to being tensioned, the torsion spring can be wound.

[0368] In an alternative embodiment, the motor mechanism includes a compression drive spring, wherein the activation tab includes a helical surface portion, wherein the engageable surface portion of the drive tube for activating the drive tube includes a helical surface portion, wherein the activation tab is adapted to cause an initial rotation of the drive tube in the dosing direction in response to engaging the tab and resisting the biasing force of the compression spring and moving the drive tube between the distal position and the proximal position, and wherein the helical portion of the housing assembly and the compression spring are adapted to provide further rotation of the drive tube in response to the initial rotation, thereby enabling delivery of a complete fixed dose.

[0369] The tabs correspond to the tabs 183 , 283 of the first and second exemplary embodiments.

[0370] In an alternative embodiment, the piston rod comprises an axially extending track, wherein the transmission tube comprises an inward protrusion adapted to slidably engage the axial track, whereby the transmission tube is rotationally locked relative to the piston rod.

[0371] In an alternative embodiment, the axial portion and the helical portion of the guide structure of the housing are respectively an axial surface portion and a helical surface portion, and wherein the axial portion and the helical portion of the guide structure of the transmission tube are respectively an axial surface portion and a helical surface portion.

[0372] In an alternative embodiment, the movement of the connector from the first axial position to the second axial position is a purely axial movement.

[0373] In an alternative embodiment, the first axial position is a distal position and the second axial position is a proximal position.

[0374] In an alternative embodiment, the drug delivery device is an injection device.

[0375] In an alternative embodiment, the injection device includes a shield for operating the connector, wherein the shield is adapted to cover a portion of the needle cannula in a distal position and to expose the needle cannula in a proximal position, wherein the needle is insertable into a subject with the shield in the proximal position, and wherein in response to moving the shield from the distal position to the proximal position, the shield is adapted to move the connector between the first axial position and the second axial position, wherein the first and second positions of the connector are the distal and proximal positions.

[0376] The shield and the needle cannula correspond to the shield 110 , 210 and the needle cannula 124 , 224 of the first and second embodiments.

[0377] In an alternative embodiment, a drug delivery device 100, 200 for delivering a fixed dose, wherein the drug delivery device comprises:

[0378] - housing assembly,

[0379] -Drug reservoir with piston

[0380] a transmission mechanism, the transmission mechanism comprising: a piston rod 109, 209, the piston rod being operatively arranged in the housing assembly and being adapted to advance the piston to expel the drug during administration; and a transmission tube 180, 280, the transmission tube being operatively arranged together with the piston rod 109, 209, wherein the transmission tube 180, 280 is adapted to be axially movable relative to the housing assembly and to be prevented from rotating in a fixed state, and is adapted to be axially movable and rotatable relative to the housing in an administration state, wherein the transmission mechanism is adapted to axially move and rotate the transmission tube 180, 280 in the administration state, thereby advancing the piston rod 109, 209 in response to activation to deliver the fixed dose;

[0381] - an activation mechanism for activating the transmission mechanism in response to moving the transmission tube in an axial direction,

[0382] wherein the housing assembly comprises a guide structure for guiding the drive tube during activation and delivery of a dose, wherein the guide structure comprises: an axial portion 156, 256 providing a sliding surface for guiding the drive tube during activation and for providing a rotational stop defining an end point of a dose position, and a helical portion 157, 257 providing a sliding surface for guiding the drive tube 180, 280 during administration;

[0383] wherein the transmission tube 180, 280 comprises a guide structure comprising an axial portion 182, 282 adapted to slidably engage the axial portion of the housing assembly for activation; and a helical portion 189, 289 adapted to slidably engage the helical portion of the housing assembly during administration,

[0384] The transmission tube 180, 280 can thereby be guided along the axial portion 156, 256 without rotating, thereby being able to change from the fixed state to the dosing state during activation, thereby the transmission tube 180, 280 can be axially moved and rotated by the transmission mechanism in the dosing state, and thereby in response to the activation of the transmission mechanism, the transmission tube 180, 280 can be guided along the spiral portion 189, 289 to the end point of the dosage position, thereby changing from the dosing state to the fixed state.

[0385] In an alternative embodiment, the housing assembly further comprises internal threads, wherein the piston rod 109, 209 comprises external threads engaging the internal threads of the housing assembly, whereby the piston rod is operatively arranged with the housing.

[0386] In an alternative embodiment, the transmission tube 180, 280 is axially splined to the piston rod, thereby allowing relative axial movement and preventing relative rotation, and thereby advancing the piston rod 109, 209 in response to rotation of the transmission tube (180, 280), whereby the transmission tube is operatively arranged with the piston rod.

[0387] In an alternative embodiment, the piston rod is axially splined to the housing assembly, whereby the piston rod is axially movable and rotationally locked relative to the housing assembly, wherein the transmission tube further comprises an internal thread, wherein the piston rod further comprises an external thread, the external thread being used to threadably engage the internal thread of the transmission tube, whereby the piston rod is operatively arranged with the housing assembly and the transmission tube, and wherein the piston rod is advanced during rotation of the transmission tube, wherein the transmission mechanism comprises a motor mechanism, the motor mechanism comprising a compression transmission spring, the compression transmission spring being used to axially move the transmission tube and the piston,

[0388] wherein the drug delivery device further comprises a connector having an inclined activation tab adapted to engage an inclined surface of the drive tube and to initially rotate the drive tube in the drug delivery direction in response to engagement between the activation tab and the drive tube against the biasing force of the compression drive spring,

[0389] wherein the fixed state includes the drive tube being arrangable in: a home position, wherein the drive tube is arrangable in a first axial position, wherein the drive tube is permitted to move in one axial direction and is blocked by the housing in another axial direction; and a first angular position, wherein the drive tube is blocked from rotation in one direction by the housing and is constrained by the drive mechanism in another rotational direction, wherein the guide structure of the drive tube abuts the axial portion of the housing assembly and the helical portion of the guide structure of the housing assembly;

[0390] The administration status includes:

[0391] - the transmission tube is arrangable in a first dosing position, wherein the transmission tube is arrangable in a second axial position and in the first angular position, wherein the activation tab engages the transmission tube against the biasing force of the compression transmission spring, thereby activating the transmission mechanism, and

[0392] a second dosing position, wherein the transmission tube can be arranged in an axial position between the first axial position and the second axial position and in an angular position different from the first angular position, wherein the spiral portion (189, 289) of the guide structure can be slidably arranged at any position along the spiral portion (157, 257) of the guide structure of the housing assembly, thereby enabling the discharge of a dose

[0393] When the position of the transmission tube changes from the original position to the first drug delivery position, the transmission tube and the piston move together.

[0394] wherein the transmission tube is rotatable relative to the piston rod in response to a change in the angular position of the transmission tube from the first dosing position to the second dosing position, wherein the change in angular position relative to the housing is caused by the helical guide surface of the housing and the compression transmission spring,

[0395] wherein the transmission tube is simultaneously movable together with the piston rod in response to the axial position of the transmission tube changing from the first dosing position to the home position, wherein the change in axial position relative to the housing is caused by the helical guide surface of the housing and the compression transmission spring,

[0396] Thereby in response to activation of the transmission mechanism, a fixed dose has been delivered when the transmission tube has returned to the home position.

[0397] In another embodiment

[0398] In another embodiment, the drug delivery device includes an integrated reusable needle having a needle cleaning chamber 120 .

[0399] In an alternative embodiment, the drug delivery device includes an integrated needle magazine, wherein a plurality of needles

[0400] First list of implementation plans

[0401] 1. A drug delivery device (100, 200) for delivering a fixed dose, wherein the drug delivery device comprises:

[0402] - housing assembly,

[0403] -Drug reservoir with piston

[0404] - a transmission mechanism comprising: a piston rod (109, 209) for advancing the piston to expel the drug during drug administration; and a transmission tube (180, 280) connected to the piston rod (109, 209), wherein the transmission tube (180,) is rotationally arranged during drug administration so as to be adapted to advance the piston rod (109, 209), wherein the transmission mechanism is adapted to deliver a predetermined fixed dose in response to activation;

[0405] - an activation mechanism for activating the transmission mechanism in response to moving the transmission tube in an axial direction,

[0406] wherein the housing assembly comprises a guide structure for guiding the drive tube during activation and delivery of a dose, wherein the guide structure comprises: an axial portion (156, 256) providing a sliding surface, the sliding surface of the axial portion being used to guide the drive tube during activation and for providing a rotational stop defining an end point of a dose; and a helical portion (157, 257) providing a sliding surface, the sliding surface of the helical portion being suitable for guiding the drive tube (180, 280) during administration;

[0407] The transmission tube (180, 280) includes a guide structure, which includes an axial portion (182, 282), which is suitable for slidably engaging the axial portion of the housing assembly for activation; and a spiral portion (189, 289), which is used to slidably engage the spiral portion of the housing assembly during administration.

[0408] 2. A drug delivery device according to embodiment 1, wherein the guide structure (156, 157, 256, 257) of the housing assembly is a closed guide that provides a working cycle for the transmission tube, and wherein the starting position of the transmission tube and the end point of the dosage position are the same.

[0409] 3. The drug delivery device according to any one of the preceding embodiments, wherein the housing assembly further comprises an internal thread, wherein the piston rod (109, 209) comprises an external thread engaging the internal thread of the housing assembly.

[0410] 4. The drug delivery device according to any one of the preceding embodiments, wherein the transmission tube is axially splined to the piston rod.

[0411] 5. The drug delivery device according to any one of the preceding embodiments, wherein the transmission mechanism further comprises a motor mechanism for rotating the transmission tube for delivering a dose in response to activation of the transmission mechanism,

[0412] wherein the transmission tube is axially splined to the piston rod, whereby the transmission tube (180, 280) is rotationally locked relative to the piston rod (109, 209),

[0413] The transmission mechanism further comprises a return mechanism for moving the transmission tube in an axial direction after being activated, thereby returning the transmission tube.

[0414] 6. A drug delivery device according to any of the preceding embodiments, wherein the trigger mechanism comprises a movably arranged connector (170, 270), wherein the connector comprises an activation tab (178, 278), and wherein the activation tab is adapted to engage a surface portion (183.1, 283.1) of the transmission tube in response to moving the connector in an axial direction, whereby the connector is operatively connected to the transmission mechanism and adapted to trigger the transmission mechanism, wherein the surface portion (183.1, 283.1) is oriented in a direction toward the activation tab (178, 278).

[0415] 7. The drug delivery device according to any one of the preceding embodiments, wherein the drug delivery device comprises:

[0416] a fixed state, wherein the transmission tube (180) is arranged in a first axial position and a first angular position, wherein the transmission tube is locked to the housing, wherein the guide structure (182, 189, 282, 289) of the transmission tube abuts the axial portion (156, 256) of the housing assembly and the helical portion (157, 257) of the guide structure of the housing assembly,

[0417] a first dosing state, in which the transmission tube (180, 280) is arranged in a second axial position and in the first angular position, whereby the transmission mechanism is activated, and

[0418] - a second dosing state, wherein the spiral portion (189, 289) of the guide structure is slidably arranged along the spiral portion (157, 257) of the guide structure of the housing assembly, thereby enabling the expulsion of a dose.

[0419] 8. A drug delivery device according to embodiment 7, wherein in response to moving the connector (170, 270) from a first axial position to a second axial position, the connector (170, 270) is suitable for moving the transmission tube between the first axial position and the second axial position, thereby changing the drug delivery device (100, 200) from the fixed state to the first dosing state, and wherein in response to setting the injection device in the first dosing state, the transmission mechanism is suitable for rotating the transmission tube, thereby changing the injection device from the first dosing state to the fixed state through the second dosing state.

[0420] 9. A drug delivery device according to any of the preceding embodiments, wherein the motor mechanism comprises a torsion transmission spring (108, 208) for rotating the transmission tube by unwinding, wherein the transmission spring (108, 208) is fixed between the housing assembly and the transmission tube (180, 280), wherein the transmission spring is also compressible for axially moving the transmission tube distally during rotation, whereby the transmission spring provides the return mechanism for returning the transmission tube after activation.

[0421] 10. The drug delivery device according to embodiment 9, wherein the transmission spring (108, 208) comprises a compressible section (108.4).

[0422] 11. A drug delivery device according to any one of embodiments 9 to 10, wherein the activation tab (178, 278) includes a lateral surface portion, and wherein the engageable surface portion (183.1, 283.1) of the transmission tube is lateral, thereby providing initiation of drug administration through rotational movement caused by the torsion transmission spring.

[0423] 12. A drug delivery device according to any one of embodiments 1 to 8, wherein the motor mechanism includes a compression transmission spring, wherein the activation tab (178, 278) includes a helical surface portion, wherein the engageable surface portion (183.1, 283.1) of the transmission tube for activating the transmission tube includes a helical surface portion, wherein in response to engaging the tab (183, 283) and resisting the biasing force of the compression spring and moving the transmission tube between the distal position and the proximal position, the activation tab is suitable for causing an initial rotation of the transmission tube in the dosing direction, and wherein the helical portion (157.257) of the housing assembly and the compression spring are suitable for providing further rotation of the transmission tube in response to the initial rotation, thereby enabling delivery of a complete fixed dose.

[0424] 13. A drug delivery device according to any of the preceding embodiments, wherein the piston rod (109, 209) includes an axially extending track (109.2), wherein the transmission tube (180, 280) includes an inward protrusion (180.2), which is suitable for slidably engaging the axial track (109.2), thereby the transmission tube (180, 280) is rotationally locked relative to the piston rod (109, 210).

[0425] 14. A drug delivery device according to any of the preceding embodiments, wherein the drug delivery device further comprises a shield (110, 210) for operating the connector (170, 270), wherein the shield is adapted to cover a portion of the needle cannula (124) at a distal position and to expose the needle cannula at a proximal position, wherein the needle is insertable into a subject with the shield in the proximal position, and wherein in response to moving the shield from the distal position to the proximal position, the shield is adapted to move the connector (170, 270) between the first axial position and the second axial position, wherein the first position and the second position of the connector are a distal position and a proximal position.

[0426] 15. A drug delivery device according to embodiments 1 or 2, wherein the piston rod is axially splined to the housing assembly, whereby the piston rod is axially movable and rotationally locked relative to the housing assembly, wherein the transmission tube (180, 280) further comprises an internal thread, wherein the piston rod (109, 209) further comprises an external thread, wherein the external thread is used to threadably engage the internal thread of the transmission tube (180, 280), whereby the piston rod is operatively connected to the housing assembly and the transmission tube, and wherein the piston rod is advanced during rotation, wherein the motor mechanism comprises a compression transmission spring, wherein the compression transmission spring is used to axially move the transmission tube and the piston, whereby the transmission mechanism and the drive return guide are suitable for returning the transmission tube to the first position.

[0427] Second list of implementation plans

[0428] 1. A drug delivery device (100, 200) for delivering a fixed dose, wherein the drug delivery device comprises:

[0429] - housing assembly,

[0430] -Drug reservoir with piston

[0431] - a transmission mechanism, the transmission mechanism comprising: a piston rod (109, 209) operatively arranged in the housing assembly and adapted to advance the piston to expel the drug during administration; and a transmission tube (180, 280) operatively arranged together with the piston rod (109, 209), wherein the transmission tube (180, 280) is adapted to be axially movable relative to the housing assembly and prevented from rotating in a fixed state, and is adapted to be axially movable and rotatable relative to the housing in a dosing state, wherein the transmission mechanism is adapted to axially move and rotate the transmission tube (180, 280) in the dosing state, thereby advancing the piston rod (109, 209) in response to activation to deliver the fixed dose;

[0432] - an activation mechanism for activating the transmission mechanism in response to moving the transmission tube in an axial direction,

[0433] wherein the housing assembly comprises a guide structure for guiding the drive tube during activation and delivery of a dose, wherein the guide structure comprises: an axial portion (156, 256) providing a sliding surface, the sliding surface of the axial portion being used to guide the drive tube during activation and for providing a rotational stop defining an end point of a dose position; and a helical portion (157, 257) providing a sliding surface, the sliding surface of the helical portion being suitable for guiding the drive tube (180, 280) during administration;

[0434] wherein the transmission tube (180, 280) includes a guide structure including an axial portion (182, 282) adapted to slidably engage the axial portion of the housing assembly for activation; and a helical portion (189, 289) adapted to slidably engage the helical portion of the housing assembly during administration,

[0435] The transmission tube (180, 280) can thereby be guided along the axial portion (156, 256) without rotating and can thereby be changed from the fixed state to the dosing state during activation, the transmission tube (180, 280) can thereby be axially moved and rotated by the transmission mechanism in the dosing state, and thereby in response to activation of the transmission mechanism, the transmission tube (180, 280) can be guided along the circumferential portion (189, 289) to the end point of the dosage position, thereby changing from the dosing state to the fixed state.

[0436] 2. A drug delivery device according to embodiment 1, wherein the guide structure (156, 157, 256, 257) of the housing assembly is a closed guide that provides a working cycle for the transmission tube, and wherein the starting position of the transmission tube and the end point of the dosage position are the same.

[0437] 3. The drug delivery device according to any one of the preceding embodiments, wherein the housing assembly further comprises an internal thread, wherein the piston rod (109, 209) comprises an external thread engaging the internal thread of the housing assembly.

[0438] 4. A drug delivery device according to any of the preceding embodiments, wherein the drive tube is axially splined to the piston rod, thereby allowing relative axial movement and preventing relative rotation, and thereby advancing the piston rod (109, 209) in response to rotation of the drive tube (180, 280).

[0439] 5. The drug delivery device according to any one of the preceding embodiments, wherein the transmission mechanism further comprises a motor mechanism for rotating the transmission tube for delivering a dose in response to activation of the transmission mechanism,

[0440] wherein the transmission tube is axially splined to the piston rod, whereby the transmission tube (180, 280) is axially movable and rotationally locked relative to the piston rod (109, 209),

[0441] The transmission mechanism further comprises a return mechanism for moving the transmission tube in an axial direction after being activated, thereby returning the transmission tube.

[0442] 6. A drug delivery device according to any of the preceding embodiments, wherein the trigger mechanism comprises a movably arranged connector (170, 270), wherein the connector comprises an activation tab (178, 278), and wherein the activation tab is adapted to engage a surface portion (183.1, 283.1) of the transmission tube in response to moving the connector in an axial direction, whereby the connector is operatively connected to the transmission mechanism and adapted to trigger the transmission mechanism, wherein the surface portion (183.1, 283.1) is oriented in a direction toward the activation tab (178, 278).

[0443] 7. A drug delivery device according to any one of the preceding embodiments, wherein the fixed state includes the drive tube (180) being able to be arranged in: a home position, wherein the drive tube (180, 280) is able to be arranged in a first axial position, wherein the drive tube is allowed to move in one axial direction and is blocked by the housing in another axial direction; and a first angular position, wherein the drive tube is prevented from rotating in one direction by the housing and is constrained by the drive mechanism in another rotational direction, wherein the guide structure (182, 189, 282, 289) of the drive tube abuts the axial portion (156, 256) of the housing assembly and the spiral portion (157, 257) of the guide structure of the housing assembly; wherein the administration state includes:

[0444] the transmission tube is arrangable in a first dosing position, wherein the transmission tube (180, 280) is arrangable in a second axial position and in the first angular position, whereby the transmission mechanism is activated, and

[0445] - a second dosing position, wherein the transmission tube is arrangeable in an axial position between the first axial position and the second axial position, and in an angular position different from the first angular position, wherein the helical portion (189, 289) of the guide structure is slidably arranged along the helical portion (157, 257) of the guide structure of the housing assembly, thereby enabling the discharge of a dose.

[0446] 8. A drug delivery device according to embodiment 7, wherein in response to moving the connector (170, 270) from a first axial position to a second axial position, the connector (170, 270) is suitable for moving the transmission tube between the first axial position and the second axial position, thereby changing the position of the transmission tube (180, 280) from the original position to the first dosing position, and wherein in response to activating the transmission mechanism by setting the transmission tube (180, 280) in the first dosing position, the transmission mechanism is suitable for rotating the transmission tube (180, 280), thereby changing the position of the transmission tube (180, 280) from the first dosing position to the second dosing position and the original position.

[0447] 9. A drug delivery device according to any of the preceding embodiments, wherein the motor mechanism comprises a torsion transmission spring (108, 208) for rotating the transmission tube by unwinding, wherein the transmission spring (108, 208) is fixed between the housing assembly and the transmission tube (180, 280), wherein the transmission spring is also compressible for axially moving the transmission tube during rotation, whereby the transmission spring provides the return mechanism for returning the transmission tube after activation.

[0448] 10. The drug delivery device according to embodiment 9, wherein the transmission spring (108, 208) comprises a compressible section (108.4).

[0449] 11. A drug delivery device according to any one of embodiments 9 to 10, wherein the activation tab (178, 278) of the connector (170, 270) includes a lateral surface portion, and wherein the engageable surface portion (183.1, 283.1) of the transmission tube is lateral, thereby enabling the initiation of drug administration to be provided by rotational movement caused by the torsion transmission spring in response to activation of the transmission mechanism.

[0450] 12. A drug delivery device according to any one of embodiments 1 to 8, wherein the motor mechanism includes a compression transmission spring, wherein the activation tab (178, 278) includes a helical surface portion, wherein the engageable surface portion (183.1, 283.1) of the transmission tube for activating the transmission tube includes a helical surface portion, wherein in response to engaging the tab (183, 283) and resisting the biasing force of the compression spring and moving the transmission tube between the distal position and the proximal position, the activation tab is suitable for causing an initial rotation of the transmission tube in the dosing direction, and wherein the helical portion (157.257) of the housing assembly and the compression spring are suitable for providing further rotation of the transmission tube in response to the initial rotation, thereby enabling delivery of a complete fixed dose.

[0451] 13. A drug delivery device according to any of the preceding embodiments, wherein the piston rod (109, 209) includes an axially extending track (109.2), wherein the transmission tube (180, 280) includes an inward protrusion (180.2), which is suitable for slidably engaging the axial track (109.2), whereby the transmission tube (180, 280) is rotationally locked relative to the piston rod (109, 210) and is allowed to move axially.

[0452] 14. A drug delivery device according to any of the preceding embodiments, wherein the drug delivery device further comprises a shield (110, 210) for operating the connector (170, 270), wherein the shield is adapted to cover a portion of the needle cannula (124) at a distal position and to expose the needle cannula at a proximal position, wherein the needle is insertable into a subject with the shield in the proximal position, and wherein in response to moving the shield from the distal position to the proximal position, the shield is adapted to move the connector (170, 270) between the first axial position and the second axial position, wherein the first position and the second position of the connector are a distal position and a proximal position.

[0453] 15. A drug delivery device according to embodiment 1 or 2, wherein the piston rod is axially splined to the housing assembly, whereby the piston rod is axially movable and rotationally locked relative to the housing assembly, wherein the transmission tube further comprises an internal thread, whereby the piston rod is operatively arranged in the housing assembly, wherein the piston rod further comprises an external thread, the external thread being used to threadably engage the internal thread of the transmission tube, whereby the piston rod is operatively arranged with the housing assembly and the transmission tube, and wherein the piston rod is advanced during rotation of the transmission tube, wherein the transmission mechanism comprises a motor mechanism, the motor mechanism comprising a compression transmission spring, the compression transmission spring being used to axially move the transmission tube and the piston,

[0454] wherein the drug delivery device further comprises a connector having an inclined activation tab adapted to engage an inclined surface of the drive tube and to initially rotate the drive tube in the drug delivery direction in response to engagement between the activation tab and the drive tube against the biasing force of the compression drive spring,

[0455] wherein the fixed state includes the drive tube being arrangable in: a home position, wherein the drive tube is arrangable in a first axial position, wherein the drive tube is permitted to move in one axial direction and is blocked by the housing in another axial direction; and a first angular position, wherein the drive tube is blocked from rotation in one direction by the housing and is constrained by the drive mechanism in another rotational direction, wherein the guide structure of the drive tube abuts the axial portion of the housing assembly and the helical portion of the guide structure of the housing assembly;

[0456] The administration status includes:

[0457] - the transmission tube is arrangable in a first dosing position, wherein the transmission tube is arrangable in a second axial position and in the first angular position, wherein the activation tab engages the transmission tube against the biasing force of the compression transmission spring, thereby activating the transmission mechanism, and

[0458] a second dosing position, wherein the transmission tube can be arranged in an axial position between the first axial position and the second axial position and in an angular position different from the first angular position, wherein the spiral portion (189, 289) of the guide structure can be slidably arranged at any position along the spiral portion (157, 257) of the guide structure of the housing assembly, thereby enabling the discharge of a dose

[0459] When the position of the transmission tube changes from the original position to the first drug delivery position, the transmission tube and the piston move together.

[0460] wherein the transmission tube is rotatable relative to the piston rod in response to a change in the angular position of the transmission tube from the first dosing position to the second dosing position, wherein the change in angular position relative to the housing is caused by the helical guide surface of the housing and the compression transmission spring,

[0461] wherein the transmission tube is simultaneously movable together with the piston rod in response to the axial position of the transmission tube changing from the first dosing position to the home position, wherein the change in axial position relative to the housing is caused by the helical guide surface of the housing and the compression transmission spring,

[0462] Thereby in response to activation of the transmission mechanism, a fixed dose has been delivered when the transmission tube has returned to the home position.

[0463] In the above description of the exemplary embodiments, different structures and means for providing the functions described for different components have been described to the extent that the concept of the invention will be clear to those skilled in the art. The detailed construction and description of the different components are considered to be the purpose of the normal design process performed by those skilled in the art along the lines set out in this specification.

Claims

1. A drug delivery device (100, 200) for delivering a fixed dose, wherein the drug delivery device comprises: Housing components, Drug reservoir with piston A transmission mechanism, the transmission mechanism comprising: a piston rod (109, 209) operatively arranged in the housing assembly and adapted to advance the piston to expel the drug during administration; and a transmission tube (180, 280) operatively arranged together with the piston rod (109, 209), wherein the transmission tube (180, 280) is adapted to be axially movable relative to the housing assembly and prevented from rotating in a fixed state, and is adapted to be axially movable and rotatable relative to the housing in a dosing state, wherein the transmission mechanism is adapted to axially move and rotate the transmission tube (180, 280) in the dosing state, thereby advancing the piston rod (109, 209) in response to activation to deliver the fixed dose; an activation mechanism for activating the transmission mechanism in response to moving the transmission tube in an axial direction, wherein the housing assembly comprises a guide structure for guiding the drive tube during activation and delivery of a dose, wherein the guide structure comprises: an axial portion (156, 256) providing a sliding surface, the sliding surface of the axial portion being used to guide the drive tube during activation and for providing a rotational stop defining an end point of a dose position; and a circumferential portion (157, 257) providing a sliding surface, the sliding surface of the circumferential portion being suitable for guiding the drive tube (180, 280) during administration; wherein the transmission tube (180, 280) includes a guide structure including an axial portion (182, 282) adapted to slidably engage a corresponding axial portion of the housing assembly for activation; and a circumferential portion (189, 289) adapted to slidably engage a corresponding circumferential portion of the housing assembly during administration, The transmission tube (180, 280) can thereby be guided along the axial portion (156, 256) without rotating, thereby being able to change from the fixed state to the dosing state during activation, whereby the transmission tube (180, 280) can be axially moved and rotated by the transmission mechanism in the dosing state, and whereby in response to activation of the transmission mechanism, the transmission tube (180, 280) can be guided along the circumferential portion (189, 289) to the end point of the dosage position, thereby changing from the dosing state to the fixed state.

2. The drug delivery device of claim 1, wherein the guide structure (156, 157, 256, 257) of the housing assembly is a closed guide that provides a working cycle for the transmission tube, and wherein the starting position of the transmission tube and the end point of the dosage position are the same.

3. A drug delivery device according to claim 1 or 2, wherein the circumferential portion (157, 257) of the guide structure of the housing assembly is a spiral portion (157, 257) or a stepped portion including at least one step, and wherein the corresponding circumferential portion (189, 289) of the guide portion of the transmission tube (180, 280) is a spiral portion (189, 289) corresponding to the spiral portion (157, 257) of the housing assembly or a stepped portion including at least one step corresponding to the stepped portion of the housing assembly.

4. A drug delivery device according to claim 1 or 2, wherein the transmission tube is axially splined to the piston rod, thereby allowing relative axial movement and preventing relative rotation, and thereby advancing the piston rod (109, 209) in response to rotation of the transmission tube (180, 280).

5. The drug delivery device of claim 3, wherein the transmission mechanism further comprises a motor mechanism for rotating the transmission tube in response to activation of the transmission mechanism for delivering a dose, wherein the transmission tube is axially splined to the piston rod, whereby the transmission tube (180, 280) is axially movable and rotationally locked relative to the piston rod (109, 209), The transmission mechanism further comprises a return mechanism for moving the transmission tube in an axial direction after being activated, thereby returning the transmission tube.

6. A drug delivery device according to claim 5, wherein the activation mechanism includes a movably arranged connector (170, 270), wherein the connector includes an activation tab (178, 278), and wherein the activation tab is suitable for engaging an engageable surface portion (183.1, 283.1) of the transmission tube in response to moving the connector in an axial direction, whereby the connector is operatively connected to the transmission mechanism and is suitable for triggering the transmission mechanism, wherein the engageable surface portion (183.1, 283.1) is oriented in a direction toward the activation tab (178, 278).

7. The drug delivery device according to claim 6, wherein the fixed state includes the drive tube (180) being able to be arranged in: a home position, wherein the drive tube (180, 280) is able to be arranged in a first axial position, wherein the drive tube is allowed to move in one axial direction and is blocked by the housing in another axial direction; and a first angular position, wherein the drive tube is prevented from rotating in one direction by the housing and is constrained by the drive mechanism in another rotational direction, wherein the guide structure (182, 189, 282, 289) of the drive tube abuts the axial portion (156, 256) of the housing assembly and the helical portion (157, 257) of the guide structure of the housing assembly; wherein the administration state includes: the transmission tube is arrangable in a first dosing position, wherein the transmission tube (180, 280) is arrangable in a second axial position and in the first angular position, whereby the transmission mechanism is activated, and - a second dosing position, wherein the transmission tube is arrangeable in an axial position between the first axial position and the second axial position, and in an angular position different from the first angular position, wherein the helical portion (189, 289) of the guide structure is slidably arranged along the helical portion (157, 257) of the guide structure of the housing assembly, thereby enabling the discharge of a dose.

8. A drug delivery device according to claim 7, wherein in response to moving the connector (170, 270) from a first axial position to a second axial position, the connector (170, 270) is suitable for moving the transmission tube between the first axial position and the second axial position, thereby changing the position of the transmission tube (180, 280) from the original position to the first dosing position, and wherein in response to activating the transmission mechanism by setting the transmission tube (180, 280) in the first dosing position, the transmission mechanism is suitable for rotating the transmission tube (180, 280) to change the position of the transmission tube (180, 280) from the first dosing position to the second dosing position and the original position.

9. A drug delivery device according to claim 8, wherein the motor mechanism includes a torsion transmission spring (108, 208) for rotating the transmission tube by unwinding, wherein the transmission spring (108, 208) is fixed between the housing assembly and the transmission tube (180, 280), wherein the transmission spring is also compressible for axially moving the transmission tube during rotation, whereby the transmission spring provides the return mechanism for returning the transmission tube after activation.

10. The drug delivery device according to claim 9, wherein the transmission spring (108, 208) comprises a compressible section (108.4).

11. A drug delivery device according to any one of claims 9 to 10, wherein the activation tab (178, 278) of the connector (170, 270) includes a lateral surface portion, and wherein the engageable surface portion (183.1, 283.1) of the transmission tube is lateral, thereby enabling the initiation of drug administration to be provided by a rotational movement caused by the torsion transmission spring in response to activation of the transmission mechanism.

12. A drug delivery device according to any one of claims 6 to 8, wherein the motor mechanism includes a compression transmission spring, wherein the activation tab (178, 278) includes a helical surface portion, wherein the engageable surface portion (183.1, 283.1) of the transmission tube for activating the transmission tube includes a helical surface portion, wherein in response to engaging the tab (183, 283) and resisting the biasing force of the compression spring and moving the transmission tube between a distal position and a proximal position, the activation tab is suitable for causing an initial rotation of the transmission tube in the administration direction, and wherein the helical portion (157.257) of the housing assembly and the compression spring are suitable for providing further rotation of the transmission tube in response to the initial rotation, thereby enabling delivery of a complete fixed dose.

13. A drug delivery device according to claim 1 or 2, wherein the piston rod (109, 209) includes an axially extending track (109.2), wherein the transmission tube (180, 280) includes an inward protrusion (180.2), which is suitable for slidably engaging the axial track (109.2), whereby the transmission tube (180, 280) is rotationally locked relative to the piston rod (109, 210) and is allowed to move axially.

14. The drug delivery device according to claim 7 or 8, wherein the drug delivery device further comprises a shield (110, 210) for operating the connector (170, 270), wherein the shield is adapted to cover a portion of the needle cannula (124) at a distal position and to expose the needle cannula at a proximal position, wherein, With the shield in the proximal position, a needle is insertable into a subject, and wherein in response to moving the shield from the distal position to the proximal position, the shield is adapted to move the connector (170, 270) between the first axial position and the second axial position, wherein the first axial position and the second axial position of the connector are a distal position and a proximal position.

15. The drug delivery device of claim 3, wherein the piston rod is axially splined to the housing assembly, whereby the piston rod is axially movable and rotationally locked relative to the housing assembly, wherein the transmission tube further comprises an internal thread, whereby the piston rod is operatively arranged in the housing assembly, wherein the piston rod further comprises an external thread, the external thread being configured to threadably engage the internal thread of the transmission tube, whereby the piston rod is operatively arranged with the housing assembly and the transmission tube, and wherein the piston rod is advanced during rotation of the transmission tube, wherein the transmission mechanism comprises a motor mechanism, the motor mechanism comprising a compression transmission spring, the compression transmission spring being configured to axially move the transmission tube and the piston, wherein the drug delivery device further comprises a connector having an inclined activation tab adapted to engage an inclined surface of the drive tube and to initially rotate the drive tube in the drug delivery direction in response to engagement between the activation tab and the drive tube against the biasing force of the compression drive spring, wherein the fixed state includes the drive tube being arrangable in: a home position, wherein the drive tube is arrangable in a first axial position, wherein the drive tube is permitted to move in one axial direction and is blocked by the housing in another axial direction; and a first angular position, wherein the drive tube is blocked from rotation in one direction by the housing and is constrained by the drive mechanism in another rotational direction, wherein the guide structure of the drive tube abuts the axial portion of the housing assembly and the helical portion of the guide structure of the housing assembly; The administration status includes: - the transmission tube is arrangable in a first dosing position, wherein the transmission tube is arrangable in a second axial position and in the first angular position, wherein the activation tab engages the transmission tube against the biasing force of the compression transmission spring, thereby activating the transmission mechanism, and a second dosing position, wherein the transmission tube can be arranged in an axial position between the first axial position and the second axial position and in an angular position different from the first angular position, wherein the spiral portion (189, 289) of the guide structure can be slidably arranged at any position along the spiral portion (157, 257) of the guide structure of the housing assembly, thereby enabling the discharge of a dose When the position of the transmission tube changes from the original position to the first drug delivery position, the transmission tube and the piston move together. wherein the transmission tube is rotatable relative to the piston rod in response to a change in the angular position of the transmission tube from the first dosing position to the second dosing position, wherein the change in angular position relative to the housing is caused by the helical guide surface of the housing and the compression transmission spring, wherein the transmission tube is simultaneously movable together with the piston rod in response to the axial position of the transmission tube changing from the first dosing position to the home position, wherein the change in axial position relative to the housing is caused by the helical guide surface of the helical portion of the housing and the compression transmission spring, Thereby in response to activation of the transmission mechanism, a fixed dose has been delivered when the transmission tube has returned to the home position.